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 Otopetrin family genes encode multi-transmembrane domain proteins with three 
highly conserved domains. In mice, three Otopetrin paralogues are found. One of its 
members, Otopetrin 1 (Otop1) has been previously shown to be essential for the 
formation of otoconia in the vestibular system of the inner ear. Otoconia are calcium 
carbonate biominerals that are required for normal balance and the sensation of linear 
acceleration with respect to gravity. The mechanism by which OTOP1 mediates otoconia 
biosynthesis is not known, but the ability of OTOP1 to modulate [Ca2+]i in response to 
purinergic signals in heterologous systems suggest that OTOP1 may be involved in 
concentrating [Ca2+] within the sensory epithelium and/or the globular substance vesicles, 
which are secreted from the epithelium. In this study, we generated null alleles of Otop1 
(Otop1βgal/βgal) and Otop2 (Otop2nβgal/nβgal) in mice to investigate the in vivo functions of 
these genes. The otoconial agenesis phenotype in Otop1βgal/βgal mice suggests that the 
most sensitive and important role for OTOP1 during development is mediating otoconia 
formation. X-gal staining and immunohistochemical analysis reveal that Otop1 is 
expressed in the developing and adult supporting cells in the non-striola region of the 
maculae. Within these sensory epithelia, OTOP1 localizes near the apical end. In primary 
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utricular macular cultures, endogenous OTOP1 is necessary to inhibit P2Y function and 
the influx of extracellular Ca2+ in a Ca2+- and ATP-dependent manner. The two different 
recessive missense mutations of Otop1, tilted (tlt) and mergulhador (mlh), result in the 
same phenotype as in Otop1βgal/βgal, suggesting that they have inactivated essential 
OTOP1 activity. Localization studies and ratiometric Ca2+ imaging in COS7 cells and 
primary utricular macular cultures show that both tlt and mlh alter normal localization of 
OTOP1 and that the mlh mutation has a greater effect on modulating [Ca2+]i compared to 
tlt. When examined in heterologous systems, OTOP2 and 3 can modulate [Ca2+]i in a 
similar manner to OTOP1, suggesting possible functional redundancy between Otopetrins. 
However, the double knockout allele for Otop1 and Otop2 does not exhibit additional 
phenotypes, suggesting that these genes may have more prominent functional redundancy 
with OTOP3. Alternatively, a subtler phenotype may exist but will require a more careful 
analysis to be revealed. Because otoconia formation is affected by altered gravity it is 
possible that the genes important for otoconia biosynthesis, such as Otoconin90 and 
Otop1, may also be affected. However, a quantitative RT-PCR analysis of quail embryo 
development under constant hypergravity conditions shows that expression of these genes 
is not significantly affected by altered gravity treatment. This result indicates that gravity 
is unlikely to serve as an epigenetic factor for these two genes during development of 
otoconia.  
 
 
 
 
 
 
 
 
 iii
ACKNOWLEDGMENTS 
I would like to thank my thesis committee members, Drs. David Ornitz, Thomas 
Baranski, David Dickman, Paul Schlesinger, Thomas Steinberg, and Mark Warchol for 
sharing their expertise and providing helpful advice.  
I would also like to thank the Program in Molecular Cell Biology for providing 
the opportunity to participate in excellent research and their support throughout my study. 
In addition, I would like to thank the Department of Developmental Biology and 
Department of Otolaryngology for creating an intellectually stimulating and collaborative 
environment. I am particularly indebted to Dr. David Ornitz and the members of the 
Ornitz lab for their helpful discussions and support. 
This project was aided by collaboration with laboratories within Washington 
University as well as Boys Town National Research Hospital and National Institute of 
Deafness and Other Communication Disorders. I am particularly grateful for the generous 
funding provided for this project through grants from National Institute of Health.  
 
 
 
 
 
 
 
 
 
 iv
TABLE OF CONTENTS 
Abstract…….………………………………………………………………………….ii-iii 
Acknowledgments……………………………………………………………………….iv 
Table of Contents……………………………………………………………………..v-vii  
List of Figures………………………………………………….................................viii-ix 
Introduction………………………………………………………………………………1 
   Structure and development of otoconia and otolithic membrane…………………2  
            Tilted/Mergulhador and Otopetrin 1……………………………………………...3 
            Otopetrin gene family……………………………………………………………..4 
            Biochemical function of OTOP1 in vitro……………………………..…………...5              
            Summary……………………………………………………………….………….7  
 References……………………………………………………………….………...8 
            Legends and Figures……………………………………………………………..11 
            Table……………………………………………………………………………..18 
Chapter I: Otopetrin 1 regulates purinergic signaling in vivo in vestibular 
supporting cells…………………………………………………………………………19 
 
 Abstract…………………………………………………………………………..20 
            Introduction………………………………………………………………………21 
 Materials and Methods…………………………………………………………...24 
 Results……………………………………………………………………………31 
            Conclusion………………………………………………………………….........40 
 References………………………………………………………………….…….45 
 Legends and Figures……………………………………………………………..51 
 v
Chapter II: Tlt and mlh differentially disrupt OTOP1 function…………………….66 
 Introduction………………………………………………………………………67 
 Materials and Methods…………………………………………………………...69 
 Results……………………………………………………………………………73 
 Conclusion……………………………………………………………………….77 
 References………………………………………………………………………..78 
 Legends and Figures……………………………………………………………..80 
 
Chapter III: Generation and characterization of Otop2nβgal mice…………………..88 
 Introduction………………………………………………………………………89 
 Materials and Methods…………………………………………………………...91 
 Results……………………………………………………………………………96 
 Future Directions………………………………………………………………...99 
 References………………………………………………………………………101 
 Legends and Figures……………………………………………………………102 
 
Chapter IV: Comparison of otoconia weight and expression of Otopetrin 1 and 
Otoconin 90 at normal and hypergravity in developing quail……………………...106    
             
            Introduction……………………………………………………………………..107 
 Materials and Methods………………………………………………………….110 
 Results…………………………………………………………………………..113 
 Conclusion……………………………………………………………………...115 
 References………………………………………………………………………117 
 Legends and Figures……………………………………………………………121 
 
 vi
Conclusion and Future Directions……………………………………………………137 
 Conclusion……………………………………………………………………...138 
 Future Directions…………………………………………………………….....141 
 References………………………………………………………………...…….148 
Appendix……………………………………………………………………………….150 
            Technique for dissecting adult inner ear………………………………………..151 
Curriculum Vitae…………………………………………………………………...…152 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii
LIST OF FIGURES 
Introduction 
 Figure 1. Structure of the inner ear and the otoconial organs.  
 Figure 2. Predicted secondary structure and topologic model for Otopetrin 1  
            insertion into the lipid bilayer and expression of Otop1 mRNA. 
 Figure 3. Purinergic receptor signaling cascade.  
Chapter I: Otopetrin 1 regulates purinergic signaling in vivo in vestibular 
Supporting cells     
 
            Figure 1. Targeting the Otopetrin 1 (Otop1) gene.             
            Figure 2. Spatial and temporal expression of OTOP1βGAL. 
            Figure 3. OTOP1 is localized at the apex of supporting cells. 
            Figure 4. OTOP1 regulation of the purinergic response in primary chick utricular  
            macular cultures. 
 
            Figure 5. Purinergic response of organotypic macular cultures from the utricles of  
            P0-P3 mice. 
 
            Figure 6. Purinergic response of dissociated macular cultures from the utricles of  
            P0-P3 mice. 
 
            Figure 7. Semi-quantitative RT-PCR analysis of P2X and P2Y receptors in  
            Otop1+/+ mouse dissociated culture cells. 
 
Chapter II: Tlt and mlh differentially disrupt OTOP1 function  
            Figure 1. Localization of EGFPOtop1tlt and EGFPOtop1mlh in COS7 cells. 
            Figure 2. Overexpression of EGFPOtop1, EGFPOtop1tlt, and EGFPOtop1mlh in   
            COS7 cells alters the purinergic response. 
 
            Figure 3. Apical trafficking of endogenous OTOP1 is affected in Otop1tlt and  
            Otop1mlh utricular maculae. 
 
            Figure 4. Otop1tlt macular culture cells respond to ATP in a similar manner to  
            Otop1+/+. 
 
 
 
 viii
Chapter III: Generation and characterization of Otop2nβgal mice 
  
            Figure 1. Targeting scheme of Otop2nβgal allele.  
 
            Figure 2. Response of GFPOtop2 and GFPOtop3-expressing COS7 cells to  
            different purinergic agonists. 
 
Chapter IV: Comparison of otoconia size and expression of Otopetrin 1 and 
Otoconin 90 at normal and hypergravity in developing quail 
  
            Figure 1. Development of otoconia in the embryonic quail. 
 
            Figure 2. The equipment used to induce hypergravity during quail egg  
            development. 
 
            Figure 3. Oc90 in-situ hybridization and OC90 immunohistochemistry in quail  
            inner ear tissues. 
 
            Figure 4. Comparison of body weight of embryos developed at normal (1G) and  
            hypergravity (2G). 
 
            Figure 5. Relative quantification of Otogelin expression using qRT-PCR. 
 
            Figure 6. Relative quantification of Oc90 gene expression at 1G vs 2G. 
 
            Figure 7. Relative quantification of Otop1 expression at 1G vs 2G. 
 
            Figure 8. Comparison of otoconial calcium weight in 1G and 2G animal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ix
Introduction 
 The ability to sense movement with respect to gravity is a phylogenetically ancient 
system shared by organisms from plants to humans. Orientation in a gravitational field 
not only affects balance but can also affect the heart and respiratory rates (Yates and 
Miller, 1998), blood pressure (Miller et al., 1995), and emotional states (Douglas et al., 
1979). The sensory systems responsible for maintenance of equilibrium and balance in 
vertebrates are located in the vestibular portion of the inner ear. The gravity receptor lies 
within small fluid-filled sacs called the utricle and saccule (Figure 1A). The spatial 
adaptation to sense gravity is an extracellular superstructure, the otoconial complex, 
which contains high-density calcium carbonate particles called otoconia (otolith in teleost 
fish) embedded in a gelatinous (otolithic) membrane (Figure 1B). This structure couples 
forces of gravity to cilia of the sensory cells. Bending of the cilia in response to linear 
accelerations initiates the neuronal response. Human otoconia are subject to 
demineralization and to alterations in structure and composition (Figure 1D) because of 
aging, disease and exposure to commonly used medications, including diuretics, 
antibiotics, and psychiatric medicines (Hughes et al., 2006). These different forms of 
damage to the otoconial membrane lead to vertigo, a leading cause of falls in the elderly 
resulting in injury and death (Oghalai et al., 2000). Moreover, mammals cannot 
regenerate otoconia once they are damaged or lost. Despite such clinical significance, 
little information has been compiled about the development and maintenance of otoconia 
in humans.  
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Structure and development of otoconia and otolithic membrane  
The otoconial complex is divided into 3 layers (Figure 1B). Beginning in the 
endolymphatic space, (a) the otoconial layer contains thousands of otoconia, 0.1 to 25 µm 
biominerals consisting of a glycoprotein/proteoglycan core surrounded by minute 
crystallites (Figure 1C), and the fibrous proteins that attach them to the underlying matrix, 
(b) the gelatinous layer is glutinous and amorphous, and (c) the subcupular meshwork 
(also called the veils) is a dense reticular network of fibrillar proteins that surround the 
processes of sensory hair cells. This complex extracellular structure is established in mid 
embryonic development within the aqueous environment of the endolymph (Hughes et al., 
2006). 
        Otoconial formation begins over the sensory epithelia of the utricle and saccule 
when the core proteins (Otoconin 90 (Oc90)) and other “minor” otoconial proteins 
(Thalmann et al., 2006) coalesce into distinct structures, with faint rhombohedral shapes 
at approximately embryonic day 14 (E14) in the mouse (Ballarino and Howland, 1982; 
Thalmann et al., 2006; Wang et al., 1998). Calcification of this proteinaceous otoconial 
precursor is rapid, with maximal mineralization occurring between E15-E16.5 (Anniko, 
1980; Anniko et al., 1987). Otoconial growth is most likely mediated through accretion of 
new calcium carbonate crystals at the pointed tips of the calcifying otoconia; this is 
supported by the localization of the calcium binding protein calbindin d28k to these sites 
in developing avian otoconia (Balsamo et al., 2000). The crystal polymorph of calcium 
carbonate in mammalian otoconia is calcite, which is the thermodynamically most stable 
form (Mann et al., 1983). Otoconia achieve essentially full size by postnatal day 7 
(Erway et al., 1986; James et al., 1969; Lim, 1973), and in mammals, it is thought that no 
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new otoconia are added after this point, although turnover of otoconial calcium has been 
observed at a low rate in the adult rodent (Lim, 1973; Preston et al., 1975). 
 The essential requirement to form calcium carbonate, the inorganic phase of 
otoconia, is the availability of Ca2+ and CO32- ions. The presence of carbonate ions 
depend on the activity of carbonic anhydrase, which is abundant in the inner ear (Lim et 
al., 1983; Shiao et al., 2005). However, little is currently known about the source of Ca2+ 
in otoconial formation.  
 
Tilted/Mergulhador and Otopetrin 1 
Several mouse strains with vestibular system pathology have missing or defective 
otoconia (Hughes et al., 2006), including tilted (tlt) and mergulhador (mlh). The tilted 
mouse arose spontaneously in a p6H/pd stock and has subsequently been bred onto a 
C57BL/6J background and cryopreserved at the Jackson Laboratory (Lane, 1986). The tlt 
locus was previously mapped to mouse chromosome 5 (Lane, 1986; Lane, 1987). The 
homozygous tilted mouse often holds its head in a slightly tilted position. Under normal 
laboratory conditions, the animal shows no other behavioral abnormalities (e.g., circling, 
head-tossing). However, when dropped into water, the mouse cannot find the surface and 
would drown if not rescued. Tlt mice lack otoconia despite normal development of the 
inner ear and other structures. The penetrance of this defect is 100 percent (Hurle et al., 
2003).  
 A second mutant allele, mergulhador (mlh), or “diver” in Portuguese, arose in an 
ENU (N-ethyl-N-nitrosourea) mutagenesis screen (Massironi et al., 1994) and exhibits 
non-swimming behavior and lack of otoconia, similar to the tlt mutant mice. 
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Homozygous mlh mice are viable and fertile. They hold their head tilted to one side, 
shake when suspended by the tail, and exhibit non-swimming behavior indicative of 
vestibular dysfunction. Mlh and tlt phenotypes are indistinguishable (Hurle et al., 2003). 
 Through positional cloning, tlt and mlh were found to be mutant alleles of a novel 
gene (Otopetrin 1, Otop1), encoding a multi-transmembrane domain protein (Hurle et al., 
2003). Both mutants carry single missense mutations leading to non-conservative amino 
acid substitutions that affect two putative transmembrane (TM) domains (tlt, 
Ala151->Glu in TM3; mlh, Leu408->Gln in TM9) (Figure 2A). 
 
Otopetrin gene family 
 Homologous genes for murine Otop1 have been identified in all vertebrate groups 
examined, including rat, human, G. gallus (chicken), F. rubripes (fugu), and D. rerio 
(zebrafish). Additionally, two Otop1-like genes (Otop2 and Otop3) were found. Mouse 
OTOP2 and OTOP3 show 34% and 30% amino acid identity with OTOP1, respectively 
(Hurle et al., 2003). Comparison of the cDNA assemblies and genomic sequence 
indicated that all Otopetrin family members share a common gene structure with 
conserved splice-site positions. Otopetrins have homology to the invertebrate Domain of 
Unknown Function 270 genes (DUF 270; pfam03189). Multi-species comparison of the 
predicted primary sequences and predicted secondary structures of 62 vertebrate 
Otopetrins, and arthropod and nematode DUF270 proteins, has found highly conserved 
domains (Otopetrin Domain I, II, and III) (Figure 2A) (Hughes et al., 2008).    
 Preliminary data on in situ hybridization, RT-PCR, microarray analysis and 
presence in EST libraries indicate that Otopetrins are expressed in many of the major 
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organs (Table 1). Considerable overlap in expression between Otop1 and Otop1 
homologues suggest possible functional redundancy. Otop1 expression was detected in 
the macular epithelia of the utricle and saccule in the inner ear, using radioactive in situ 
hybridization (Figure 2B).  
 
Biochemical function of Otop1 in vitro 
The source of calcium to form otoconia is predicted to come from the endolymph, 
which is the extracellular fluid bathing hair cells and supporting cells of the macula. 
However, the calcium concentration in the endolymph is too low (10-100µM) (Anniko, 
1980; Salt et al., 1989) to drive nucleation of calcium crystals on its own. Therefore, a 
system to concentrate these calcium ions in a closed environment is required. Several 
previous studies have observed membrane vesicles called “globular substance” in 
embryonic inner ears, which are thought to be precursors of otoconia formation that are 
extruded or budded from the apical surface of the cells of the developing utricular and 
saccular sensory epithelium (Erway et al., 1986; Preston et al., 1975; Ross, 1979; Suzuki 
et al., 1995; Tateda et al., 1998). The predicted secondary structure (integral membrane 
protein) (Figure 2A) suggests that Otop1 may be associated with the globular substance. 
Suzuki et al. showed that globular substance vesicles in isolated otoconial membranes 
had a dose-dependent response to ATP characterized by a 5-6 fold increase in 
intravesicular Ca2+ as assessed by fluo-3 fluorescence (Suzuki et al., 1997).This finding 
suggested that increasing the concentration of Ca2+ ion in globular substance vesicles 
could permit nucleation of CaCO3 crystals in a protected environment. 
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        The kinetics and concentration dependence of ATP-dependent intravesicular Ca2+ 
accumulation suggested that the ATP-mediated Ca2+ increase in globular substance had 
some similarities to known purinergic P2 receptors, which mediate intracellular Ca2+ 
increases in response to ATP (Hughes et al., 2007). Typically, ATP-dependent Ca2+ 
increases involved the activity of the P2Y or P2X receptors (Figure 4) (North, 2002; 
Ralevic and Burnstock, 1998). P2Y receptors have 7 transmembrane domains and their 
activation is coupled to the activation of G proteins. Several P2Y receptors interact with 
Gαq subunits of the G protein. Nucleotide binding to the P2Y receptor leads to the 
activation of Gαq, subsequent activation of phospholipase C and IP3 kinase and the 
generation of inositol 1, 4, 5-triphosphate (IP3). IP3 binds the IP3 receptor on the 
endoplasmic reticulum (ER) membrane, releasing ER Ca2+ stores and rapidly increasing 
intracellular cytoplasmic Ca2+ concentrations ([Ca2+]i). This change in [Ca2+]i is 
represented as a sharp spike, which is followed by a rapid return to an elevated base line 
as Ca2+ is extruded from the cytoplasm through a Plasma Membrane Ca2+-ATPase 
(PMCA) or returned to the ER through the Sarcoplasmic/Endoplasmic Reticulum Ca2+-
ATPase (SERCA). The P2X family of purinergic receptors has only 2 transmembrane 
domains. Binding of nucleotides to the extracellular domain of the P2X receptor family 
leads to opening of a non-selective cation channel formed by homo- or hetero-trimers of 
the 7 P2X family members. P2X channel opening results in an influx of extracellular 
Ca2+ into the cytoplasm, raising [Ca2+]i. The different P2 family members are 
distinguished by the source of Ca2+ (intracellular versus extracellular), nucleotide or 
nucleotide-analogue sensitivity, the use or absence of second messengers, and sensitivity 
to a variety of pharmacologic agents (North, 2002; Ralevic and Burnstock, 1998). 
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        Considering the previous genetic studies (mouse and zebrafish mutants), which 
suggests a prominent role for OTOP1 in the initiation of calcium mineralization (Hughes 
et al., 2004; Hurle et al., 2003; Ornitz et al., 1998; Sollner et al., 2004), we hypothesized 
that OTOP1 may have a role in modulating Ca2+ flux in globular substance vesicles. We 
performed single cell ratiometric Ca2+ imaging techniques to investigate changes in 
intracellular calcium regulation due to expression of Otop1 in immortalized cell lines 
(COS7, ROS cells) and primary chick utricular cultures (Hughes et al., 2007).  
Overexpression of Otop1 lead to a nonspecific depletion of endoplasmic reticulum (ER) 
Ca2+ stores, specific inhibition of the purinergic receptor P2Y2, and initiation of a novel 
P2X-like purinoceptor influx of extracellular Ca2+ in response to certain purinergic 
nucleotides (ATP=ADP>>UDP, with αßMeATP, BzATP, ATPγS, UTP, and 2-MeSATP 
not effective). All of these activities were shown to be pharmacologically and reversibly 
blocked by prolonged exposure to the polyanion suramin. This combination of activities 
is unique to OTOP1, and one or all of these activities may be required for otoconial 
development.  
 
Summary  
Previous studies showed that OTOP1 activity is vital for Otoconial formation 
(Hughes et al., 2004; Hurle et al., 2003; Sollner et al., 2004), and that expression of 
Otop1 modulates intracellular calcium regulation (Hughes et al., 2007). However, it is 
still not clear how this activity can be correlated to the developmental function of Otop1 
during otoconial formation. Besides this role, OTOP1 could have additional functions in 
other organs that express Otop1, but they are not revealed in any of the mutant mice. To 
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decipher the in vivo role of Otop1, it is necessary to examine the phenotype of a true null 
allele. In addition, because Otop1 and Otop1 homologues, Otop2 and 3, are expressed in 
overlapping patterns, we should not overlook possible functional redundancy between 
Otopetrins. Therefore, it is also vital to generate null alleles of Otopetrin genes and make 
double knockouts for further analysis. Moreover, to strengthen the hypothesis of 
functional redundancy, biochemical studies on other Otopetrins (OTOP2 and OTOP3) 
needs to be done to determine if other paralogues have similar biochemical activities as 
OTOP1. Additionally, the mutations associated with otoconial agenesis (tlt, mlh) should 
have some changes in biochemical properties.  
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Figure 1. Structure of the inner ear and the otoconial organs. A) Schematic 
representation of the mammalian inner ear (Hughes et al., 2006). The cochlea is required 
for the sensation of sound. The vestibular portion of the inner ear is made up of 5 sensory 
maculae: the anterior, posterior, and lateral semicircular canal ampullae and the utricle 
and saccule. The semicircular canals detect angular motion, whereas the utricle and 
saccule are responsible for sensation of linear motion, including gravity. Otoconia lie 
within the utricle and saccule. All of the inner ear organs are filled with endolymph fluid, 
which is low in calcium (Ca2+) and rich in potassium (K+) (Hughes et al., 2006). B) 
Schematic representation of the utricular maculae and associated structures. Figure 
adapted from (Hughes et al., 2008). A thin, nonsensory epithelium lies opposite the 
sensory macula and contains melanocytes (m), which provide trace elements in 
melanosomes to the epithelial cells, giving them a dark appearance (dc). The macula is 
composed of hair cells (hc), supporting cells (sc); transitional cells (tc) border the edges 
of the maculae. Above the macula lie the otoconia and the otolithic membrane. The 
otolithic membrane is composed of a gelatinous layer, where otoconia crystals are 
embedded, and the underlying subcupular meshwork, which surrounds the stereocilia of 
the hair cells. Otoconia are held in place on the otolithic membrane by strands of non-
collagenous extracellular matrix proteins that resemble beads on a string. C) Each 
otoconium is formed by calcium carbonate biominerals precipitated around a 
proteinaceous core. The majority of the proteinaceous core contains Otoconin90 (Oc90), 
and other minor matrix proteins (fetuin, laminin α3, osteopontin, SC-1, MyI9) have been 
discovered (Thalmann et al., 2006). D) Otoconia are prone to damage. The affected 
otoconia appear pitted or hallowed out and subsequently break into fragments, which can 
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result in displacement of otoconia into other inner ear organs. This causes abnormal 
sensations of dizziness and loss of balance.   
 12
  13
Figure 2.  Predicted secondary structure and topologic model for Otopetrin 1 
insertion into the lipid bilayer and expression of Otop1 mRNA. A) Otopetrin 1 is 
predicted to encode a 12-transmembrane domain protein with both the N- and C-termini 
in the cytosol. The locations of the tlt, mlh, and bks mutations are noted by arrows in 
TM3, TM9, and TM10, respectively. Otopetrin Domain-I, -II, and -III (OD-I, OD-II, and 
OD-III, respectively) are marked by shaded green, pink, and blue rectangles. Each amino 
acid is represented as a circle and the chemical properties of amino acids are denoted by 
color: charged residues (red), polar residues (blue), and non-polar residues (green). 
Cysteine (yellow) and proline (dark green) are noted. The two consensus N-glycosylation 
sites (N) are indicated in loop 5. The predicted intracellular and extracellular loops and 
TM domains are numbered L1 to L11 and TM1 to TM12, respectively. Figure adapted 
from (Hughes et al., 2008). B) In situ hybridization with an Otop1 probe marked Otop1 
expression in the sensory epithelium (SE). No signal is present in the non-sensory 
epithelium (arrowheads). Figure adapted from (Hurle et al., 2003). 
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Figure 3. Purinergic receptor signaling cascade. There are two classes of P2 purinergic 
receptors which modulate Ca2+ from different sources. Ionotropic P2X receptors are Ca2+ 
channels which mediate influx of extracellular Ca2+ by binding to ATP. Metabotropic 
P2Y receptors are G-protein coupled receptors, and thus stimulation with ATP activates a 
trimeric G protein. The alpha subunit then activates phospholipase β (PLCβ), which acts 
on membrane phospholipids to cleave off inositol triphosphate (IP3). Remaining in the 
membrane is the diacylglycerol (DAG). IP3 diffuses to the endoplasmic reticulum (ER), 
where it binds to the IP3 receptors. This allows intracellular Ca2+ to move out into the 
cytosol.  
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Abstract 
Otoconia are dense calcium carbonate biominerals found in the utricle and saccule 
of the inner ear that are essential for vestibular function and the normal sensation of 
gravity. In mice, missense mutations in Otopetrin 1 (Otop1) result in otoconial agenesis 
and severe deficits in balance. By replacing coding regions of Otop1 with β-
galactosidase we localized sites of Otop1 expression in the non-striolar region of the 
utricle and saccule throughout development and demonstrate that its expression persists 
in the adult. Localization of the OTOP1 protein in the apical side of supporting cells 
suggests a direct function in the regulation of apical ion flux, regulation of apical 
membrane protein activity and/or membrane trafficking. Analysis of the purinergic 
response in primary macular epithelial cultures showed that in vivo OTOP1 inhibits P2Y 
receptor-mediated release of intracellular Ca2+ stores and activates a P2X receptor-like 
influx of extracellular Ca2+. We also found that the P2Y inhibitory activity of OTOP1 
was dependent on the presence of extracellular Ca2+, suggesting a role for OTOP1 in 
sensing extracellular or intravesicular Ca2+ concentrations. These data identify an in vivo 
biochemical activity for OTOP1 and suggest a model for interaction between OTOP1 and 
apically localized purinergic receptors in the regulation of otoconia formation, 
maintenance and potentially regeneration.     
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Introduction 
Otoconia are dense calcium carbonate biominerals in the utricle and saccule of the 
vertebrate inner ear that are required for sensation of linear acceleration and gravity. 
Otoconia are composed of a proteinaceous core of calcium (Ca2+) binding and matrix 
proteins surrounded by a shell composed of calcium carbonate (CaCO3) microcrystalites 
in the form of calcite (Lins et al., 2000; Mann et al., 1983; Ross et al., 1985; Suzuki et al., 
1995; Thalmann et al., 2006). Otoconia are embedded in a fibrous extracellular matrix 
(gelatinous membrane) which couples the force of gravity to stereocilia of the underlying 
sensory hair cells. Otoconial precursors begin to form at embryonic day 14 (E14) in the 
mouse. Maximal rates of mineralization occur between E15-E16.5 (Anniko, 1980; 
Anniko et al., 1987). Otoconial growth is most likely mediated through accretion of new 
calcium carbonate crystals at the pointed tips of the calcifying otoconia (Balsamo et al., 
2000). Otoconia achieve essentially full size by postnatal day 7 (Erway et al., 1986; 
James et al., 1969; Lim, 1973), and in mammals, it is thought that no new otoconia are 
added after this point. However, turnover of otoconial calcium has been observed at a low 
rate in the adult rodents (Erway et al., 1986; Preston et al., 1975). 
Otoconia are prone to demineralization and displacement with aging, head trauma, 
and exposure to commonly used medications (Ross et al., 1976). Otoconial damage 
leading to vertigo is considered a leading cause of falls in the elderly resulting in skeletal 
fracture and accidental death (Oghalai et al., 2000). In mammals, once damaged or lost, 
otoconia cannot be regenerated. Despite clinical significance, little is known about the 
mechanisms that regulate the development and maintenance of otoconia in humans.  
Tilted (tlt) mice lack otoconia and present with a non-syndromic vestibular 
disorder (Ornitz et al., 1998). Homozygous tlt mice show a head tilting behavior and an 
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inability to swim. Positional cloning identified tlt as a mutant allele of a novel gene, 
Otopetrin 1 (Otop1) (Hurle et al., 2003). A second mutant allele, Mergulhador (mlh) 
exhibits a similar phenotype to the tlt mice. Both tlt and mlh have missense mutations (tlt, 
Ala151Glu; mlh, Leu408Gln) leading to non-conservative amino acid substitutions. In 
addition to tlt and mlh, phenotypes observed in Otop1 morphant zebrafish (Hughes et al., 
2004) and backstroke zebrafish mutant (Glu->Val) (Sollner et al., 2004) show that 
OTOP1 is essential for otolith mineralization in teleosts. Consistent with its requirement 
for otoconia formation, Otop1 is expressed in the sensory epithelium underlying the 
otoconial layer in the utricle and saccule (Hurle et al., 2003). 
Otop1 is predicted to have 12 putative TM domains, which cluster into three 
evolutionarily conserved protein domains (Hughes et al., 2008). Tlt and mlh mutations 
are located in putative TM 3 and TM 9, respectively, which are both within conserved 
regions of OTOP1. 
Otoconia are initially formed in a fibrous extracellular matrix that contains a 
vesicular structure called “globular substance” which is thought to be extruded or budded 
from the apical surface of the sensory epithelium of the utricle and saccule in the 
embryonic inner ear (Hughes et al., 2006; Suzuki et al., 1995; Tateda et al., 1998; Zhao et 
al., 2007). Suzuki et al (Suzuki et al., 1997a) showed that addition of ATP to isolated 
guinea pig globular substance vesicles resulted in a 5-6 fold increase in intravesicular 
Ca2+. This suggested that increasing the concentration of Ca2+ in globular substance 
vesicles could permit nucleation of CaCO3 crystals, and that ATP might serve as the 
trigger in vivo.  
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The role of ATP in the inner ear has been primarily studied in the cochlea 
(Housley, 2000; Lee and Marcus, 2008). Extracellular ATP affects depolarization and 
stiffness of the stereocilia of hair cells, level of Na+ and Ca2+ in the endolymph, and 
endocochlear potential which ultimately alters hearing sensitivity. In the vestibular 
system, dark cells in the non-sensory epithelium are thought to be a possible site for ATP 
release (Lee and Marcus, 2008). 
Diverse signaling pathways are activated by ATP in the inner ear (Housley, 2000), 
but the kinetics and concentration dependence of the ATP-mediated Ca2+ increase in 
globular substance vesicles (Suzuki et al., 1997a) was most similar to that of known 
purinergic P2 receptors (P2Y and P2X families). P2Y receptors are metabotrophic G-
protein coupled receptors which mediate release of Ca2+ from intracellular stores 
(Burnstock, 2007; Ralevic and Burnstock, 1998). P2X family receptors contain 
ionotrophic channels which form homo- or hetero-trimers, and binding of nucleotides 
leads to an influx of extracellular Ca2+ into the cytosol (Burnstock, 2007; North, 2002). 
Each receptor subtype in the P2 families has different sensitivities to nucleotide agonists 
and pharmacological agents (North, 2002; Ralevic and Burnstock, 1998). 
Based on the hypothesis that OTOP1 may regulate Ca2+ flux in inner ear cells, our 
previous studies demonstrated that in vitro OTOP1 is sufficient to modulate a purinergic 
response (Hughes et al., 2007). Overexpression of OTOP1 in immortalized cell lines 
leads to specific modulation of purinergic signaling mediated increase in intracellular 
calcium ([Ca2+]i); a non-specific depletion of endoplasmic reticulum (ER) Ca2+ stores, a 
specific inhibition of P2Y receptor signaling, and initiation of a novel influx of 
extracellular Ca2+.  
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Here, we have targeted the Otop1 gene by insertion of β-galactosidase. 
Homozygous null mice show a balance defect caused by otoconia agenesis with no major 
histological abnormalities in the sensory epithelia. High resolution expression studies 
localize Otop1 in the extra-striolar region of the utricle and saccule, and at the apex of 
supporting cells. In addition to the anticipated embryonic expression, we found that 
Otop1 expression persisted in the adult, suggesting a role for OTOP1 in the maintenance 
of otoconia. Calcium imaging showed that OTOP1 functions in vivo in macular 
supporting cells where it regulates purinergic signaling. These data support a role for 
OTOP1 and purinergic regulation of Ca2+ in the formation, growth and maintenance of 
otoconia.  
 
Materials and methods 
Generation of Otop1βgal/βgal allele  
The targeting construct was made using recombineering methods (Liu et al., 
2003). First, about 5 kb upstream and downstream of the regions to target was retrieved 
from BAC clone RP24-286E11 (derived from C57BL/J6 mice) which completely 
spanned the Otop1 gene. We designed a deletion of the last 62 bp of exon 2 after the 
Otop1c splice acceptor site and 2.7 kb of intron 2 and inserted the β-galactosidase (βgal) 
gene and LoxP/pol-2-neo/LoxP selectable marker (6.1 kb). To achieve this, 500 bp 
sequences immediately 5’ and 3’ of the site that we aimed to target was ligated to the 
βgal coding sequence and the neo cassette, which was excised from the PL452 vector, 
and cloned into a pBluescript vector. This construct was electroporated into DY380 cells 
already containing the retrieved BAC plasmid, and heat shock (32°C -> 42°C) was used 
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to induce homologous recombination to generate the targeting vector. The 5' and 3' 
regions of homology contained a total of 8.5 kb of genomic DNA. The targeting vector 
was verified by restriction mapping and sequencing.  
Before electroporation, the integrity and function of the OTOP1βGAL fusion 
protein was tested in tissue culture cells. The Otop1-βgal portion of the targeting vector 
was transiently expressed using lipofectamine (Invitrogen) in COS7 cells under a CMV 
promoter and cells were stained for βgal activity. OTOP1βGAL positive cells showed X-
gal staining consistent with either cytoplasmic or ER localization of the chimeric protein. 
The first 109 amino acid residues of OTOP1 containing the first two TM domains were 
also fused to EGFP and tested for known biochemical activities using a ratiometric 
calcium assay in which full length OTOP1 functions to alter cytoplasmic calcium levels 
in response to purinergic stimuli (Hughes et al., 2007). This assay (data not shown) 
demonstrated that the amino terminal two TM domains are by themselves biologically 
inactive and therefore, that the insertion of βgal and the deletion of the remaining OTOP1 
protein likely constitutes a null mutation . The targeting construct was linearized and 
electroporated into SCC-10 ES cells, which were derived from 129X1/SvJ mice. 
Electroporation was carried out in the Washington University Siteman Cancer Center 
Muring Embryonic Stem Cell Core facility. G418 resistant clones were screened for 
homologous recombination by Southern blot using 5’ probes. Two positive clones were 
identified and homologous recombination was verified using a 3’ Southern blot probe. ES 
clones were karyotyped and then microinjected into mouse blastocysts by the 
Washington University Mouse Genetics Core facility. Chimerism was determined by coat 
color and high percentage chimeric males were mated with C57BL6/J females. The 
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subsequent F1 mice were intercrossed, and the litters were examined for the germline 
transmission of the Otop1βgal allele using Southern blotting with 5’ and 3’ probes 
extrinsic to the targeting vector, and by genomic PCR (Figure 1D, E). The LoxP-neo 
cassette was excised in vivo by mating to a mouse that expressed Cre in the germ line, 
and then the male progenies were bred to C57BL6/J females to transfer the targeted allele 
onto a C57BL6/J genetic background. Phenotypes that we observed in this study 
appeared independent of genetic background. 
Southern blotting and genotyping 
Genomic DNA was extracted with phenol/choloroform and isopropanol 
precipitation. 10 μg of each sample was digested with EcoRV at 37°C overnight, and 
electrophoresed on 1% agarose gel. Southern blots were probed with 5’ and 3’ probes, 
which were labeled with 32P (Stratagene Prime-It II Random Primer Labeling Kit) and 
purified (Amersham Biosicences MicroSpin S-200 HR columns). 5’ and 3’ probes were 
made by amplification from RP24-286E11 BAC DNA with the following primers; 5’ 
probe: primer 1 (5’-CACCACGTCTAAACAAGCCA- 3’ (forward)), primer 2 (5’ - 
GCCACACAGGACTTTCTTTT- 3’ (reverse)), 3’ probe: primer 1 (5’ – 
GATAATTTCACACTGTAAGC- 3’ (forward)), primer 2 (5’ - 
GAGATTCAGTACCAATGATT- 3’ (reverse)). For genotyping PCR, mouse tail DNA 
was amplified with the following primers; primer 1 (5’-
AGGGTCTCCACAAGCTTCCGGT-3’ (forward)), primer 2 (5’-
TGACAGCCTACAGCCCAGGATG-3’ (wild-type reverse)), primer 3 (5’-
CCATTCAGGCTGCGCAACTGT-3’ (Otop1βgal reverse)). 30 cycles of denaturation at 
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94°C for 1 min, annealing at 65°C for 1 min, and extension at 68°C for 3 min were used 
to amplify either 545 (wild-type) or 369 (Otop1βgal) bp fragments. 
H&E and X-gal staining 
E16.5 temporal bones were dissected in cold PBS, and fixed in 4% 
paraformaldehyde at 4°C overnight. After washing in PBS, tissues were embedded in 
paraffin. 8 μm sections were deparaffinized and stained with Hematoxylin and eosin 
(H&E).   
For X-gal staining, temporal bones were fixed at 4°C overnight in 0.2% 
glutaraldehyde, 5 mM EGTA (pH 7.3), 100 mM MgCl2 in PBS (3.2 mM Na2HPO4, 0.5 
mM KH2PO4, 1.3 mM KCl, 135 mM NaCl, pH 7.4.). Adult temporal bones were 
decalcified in 0.35 M EDTA in 0.1 M sodium phosphate buffer (pH 7.2-7.4) before 
further processing. To make frozen sections, fixed temporal bones were incubated in 
30 % sucrose overnight and then frozen in OCT prior to cryosectioning. Whole temporal 
bones or frozen sections were stained for βgal at room temperature or 4°C in the 
following solution; 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% Nonidet-P40, 
5mM potassium ferricyanide, 5mM potassium ferrocyanide, 0.1% X-gal in PBS. After 
sufficient color development, temporal bones or sections were washed in PBS and 
imaged. 
 RNA extraction, cDNA synthesis, semi-quantitative and quantitative RT-PCR 
For detection of mouse Otop1 mRNA, tissues (utricle, saccule, cochlea, lung) 
from either 4 adult or 8 pups were dissected and pooled. For detection of chicken Otop1 
mRNA, 8 utricular epithelia were pooled for each culture and two cultures were assayed 
as each time point (1 DIV, 7 DIV). For detection of purinergic receptors, a plate of mouse 
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utricular dissociated cultures made from 8 P3 mouse pups was used.  RNA was extracted 
with Trizol (Invitrogen) and ethanol precipitation. 0.5-1 μg of RNA was treated with 
DNase I (Invitrogen) to remove genomic DNA contamination prior to cDNA synthesis 
(Invitrogen SuperScript III First-Strand Synthesis System for RT-PCR). Mouse Otop1 
mRNA levels were quantified using a TaqMan® gene expression assay (#00554705_m1, 
ABI inc.). Quantitative RT-PCR using Sybr green (ABI inc.) was used to measure chick 
Otop1 levels. Primers to chick Otop1 (Forward: 5’-
TTAATTCTGGACTCCTTTAAAATTGGA-3’, Reverse: 5’-
GAACACAGAATGGATAACCCCAAAC-3’) and GAPDH (Forward: 5’-
TGATGGGTGTCAACCATGAGA-3’, Reverse: 5’-TGGCATGGACAGTGGTCATAA-
3’) were designed. Taqman and Sybr green assays were run in a 7500 fast real-time PCR 
machine (ABI inc.). For semiquantitative RT-PCR analysis of P2X and P2Y receptors in 
mouse dissociated epithelial cultures, previously designed primers and published PCR 
conditions were used (Hayato et al., 2007). 
Production of anti-Otop1 antibody 
A rabbit polyclonal antibody was made using a 16-amino acid peptide epitope 
(ARGSPQASGPRRGASV) derived from the N-terminus of OTOP1 (Figure 1C). The 
synthetic peptide was conjugated to maleimide-activated keyhole lympet hemocyanin 
prior to injection into the rabbit.  The resulting antibody was purified on the peptide 
affinity column, and validated by Western blotting of extracts from inner ear tissues. 
Further validation was performed in this study by comparing the immunostaining patterns 
with those of X-gal staining. 
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Wholemount immunohistochemistry  
Temporal bones were isolated in Leibovitz’s medium L15 (Sigma) and fixed in 
4% paraformaldehyde for 1-2hr at room temperature. Utricular and saccular maculae 
were dissected from the temporal bones in cold PBS, incubated in 0.5% Triton X-100 for 
30 min at room temperature, and then washed with PBS. Samples were blocked using 4% 
BSA/PBS overnight at 4°C, and incubated with rabbit anti-OTOP1 (1:800) and/or mouse 
anti-parvalbumin (Sigma- 1:500) for 90 min at room temperature in a humidified 
chamber.  After washing with PBS, samples were incubated with secondary antibodies, 
Alexa 488 anti-rabbit IgG (Invitrogen- 1:600) and Alexa 555 anti-mouse IgG (Invitrogen- 
1:600), respectively, for 45 min at room temperature. For stereocilia staining, samples 
were further incubated with rhodamine-phalloidin (1:200, Invitrogen) for 15 min at room 
temperature. After washing with PBS, samples were transferred to a superfrost slide, 
mounted with vectashield (Vector labs), and coverslipped before imaging. 
Frozen section immunohistochemistry 
Frozen sections were recovered in PBS, and blocked with 4% BSA, 0.3% Triton 
in PBS. Sections were incubated with anti-OTOP1 (1:800) and anti-β-gal (1:1000) 
antibodies overnight at 4°C. After washing with 0.3% Triton in PBS, sections were 
incubated with secondary antibodies (Cy3 anti-rabbit IgG – 1:200, Alexa 488 anti-
chicken IgG – 1:600) for 2 hr at RT. Samples were mounted with vectashield (Vector 
labs). 
Utricular macular organotypic and dissociated cultures  
P0-P3 mouse utricles and 6-14 days post hatch chicken utricles were dissected in 
medium 199 (Gibco #12350039), and the nonsensory epithelium and otoconial layer were 
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completely removed. After incubation in thermolysin (25 mg diluted in 50 ml medium 
1999 (Gibco #12340030)) (Sigma) at 37°C for 50 min, the underlying stroma was 
removed and the remaining epithelial sheet was attached to a MatTek dish using ECM gel 
(Sigma). The tissue was incubated in growth media overnight at 37°C. For dissociated 
culture, isolated epithelial sheets were treated with Trypsin/EDTA (0.05%, 0.02%) for 15 
min at 37 °C. After replacing Trypsin/EDTA with Medium 199 (Gibco #12340030) cells 
were triturated 5 to 10 times and plated on laminin coated MatTek dishes and incubated 
overnight at 37°C. The next day Medium 199 (Gibco #12340030) containing 10% fetal 
bovine serum (Gibco) (growth media) was added. For transfection of chicken utricular 
macular cells, cultures were treated with Lipofectamine 2000 (Invitrogen) and 
approximately 1 μg plasmid DNA (EGFP, FLAG-Otop1 (Hughes et al., 2007)) in 
OptiMEM (Invitrogen) for 4-5 hours following manufacturer’s instructions. Cultures 
were allowed to recover overnight in growth media.  
Ratiometric calcium imaging and data analysis  
All imaging experiments were carried out at room temperature in a HEPES-
buffered salt solution (HCSS) containing, in mM: 140 NaCl, 5.4 KCl, 1 NaH2PO4, 1.8 
CaCl2, 1 MgSO4, 12 HEPES, and 5.5 D-glucose, pH 7.4±0.1. Nominally calcium-free 
media was HCSS solution without CaCl2. Organotypic or dissociated utricular macular 
cultures were loaded with fura-2 by incubation for 60 min with 5-10 µM acetoxymethyl 
(AM) ester (Invitrogen, Eugene, OR) and 0.1% Pluronic F-127 (Invitrogen, Eugene, OR) 
in HCSS (pH=7.2) at room temperature, washed with HCSS and incubated for another 60 
min to allow for ester hydrolysis. After loading, cells were imaged on an inverted 
microscope (Nikon Eclipse TE300, Nikon Inc., Melville, NY) equipped with a cooled 
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CCD camera (Cooke Corp., Auburn Hill, MI) using a 20x/0.45 Plan Fluor objective 
(Nikon). The fluorescence excitation (75 W xenon arc lamp) was provided by band-
specific filters (340 and 380 nm; Semrock, Rochester, NY) in combination with a XF73 
dichroic beam splitter (Omega Optical, Brattleboro, VA). Pairs of images were collected 
constantly at alternate excitation wavelengths. After subtracting the matching background, 
the images were divided by one another to yield ratio values for individual cells. For 
studies done with mouse macular dissociated cultures, 10 μM ionomycin was added at 
the end of each experiment to obtain the maximum ratio (340/380) in each region of 
interest. To reduce variability between experiments performed on different days, raw data 
were normalized as follows: Normalized Ratio = (R- R0)/(Rmax- R0), where R is 
individual ratio value, Rmax is the peak ratio after addition of ionomycin, R0 is the average 
of the prestimulation baseline ratio. All the data in figure 6E-I represent normalized ratios. 
Ionomycin was from Calbiochem (San Diego, CA), and bisphenol, EGTA, ATP, ADP, 
UTP, and ADP were from Sigma (St. Louis, MO).  
 
Results 
Otopetrin 1 (Otop1) deficiency results in otoconial agenesis. 
To generate a null allele for Otop1 and to create a histochemical tag to identify 
OTOP1-expressing cells the Otop1 gene was targeted by insertion of the β-galactosidase 
(βgal) coding sequence. Otop1 has seven exons and three identified amino terminal 
alternative splice variants, Otop1a, 1b and 1c (Figure 1A, B). Although Otop1a is the 
most abundant splice variant expressed in the inner ear (Hurle et al., 2003), to ensure 
generation of a null allele, the βgal cDNA was inserted in frame in exon 2 such that all 
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known splice variants would be captured as fusion proteins with βGAL. This 
configuration created an OTOP1-βGAL fusion protein that includes 109 amino acid 
residues of OTOP1a, 107 amino acid residues of OTOP1b or 41 amino acid residues of 
OTOP1c amino terminal coding sequence fused at amino acid residue 5 of βGAL. This 
design expressed Otop1βgal transcripts under the control of Otop1 transcriptional 
regulatory elements. For the Otop1a and Otop1b transcripts, this fusion protein includes 
the first two transmembrane (TM) domains of OTOP1 (Figure 1C). The germ-line 
transmitted targeted allele was bred to homozygosity (confirmed by Southern blotting 
and genomic PCR (Figure 1D, E)). Heterozygous Otop1βgal/+ mice were phenotypically 
normal (Figure 1F, G). Otop1βgal/βgal mice showed vestibular dysfunction (inability to 
swim) and otoconial agenesis (Figure 1F, H). The sensory epithelium of the utricle and 
saccule were histologically normal.  
OTOP1βGAL expression in the vestibular sensory epithelium. 
The spatial and temporal expression pattern of OTOP1βGAL in the inner ear was 
assessed by X-gal staining. βGAL activity was first apparent at E13.5 in the utricle 
(Figure 2A). By E16.5, staining intensity increased in the utricle and became apparent in 
the saccule (Figure 2B). This expression pattern correlated with the onset and maximal 
rate of otoconial synthesis in the utricle and saccule (Anniko, 1980; Anniko et al., 1987). 
Importantly, at this stage no expression was observed in any other inner ear organs or 
structures (semicircular canals or cochlea). At E18.5, however trace βGAL activity was 
occasionally detected in the endolymphatic sac (data not shown). Examination of whole 
maculae after X-gal staining revealed a striking absence of expression in the striolar 
region of the utricle and saccule (Figure 2C, E), a pattern that persisted in adult mice. In 
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addition to expression in non-striolar regions of the macula, some transitional cells were 
also positive for βGAL activity (Figure 2D), indicating possible involvement of a subset 
of transitional cells during otoconial development.  
Histological sections through the maculae revealed a staining pattern consistent 
with expression in supporting cells and transitional cells (Figure 2F, G). Within 
supporting cells, X-gal staining was observed at three locations; above supporting cell 
nuclei, in the middle, or at the apex of supporting cells. Because the OTOP1-βGAL 
protein contains two putative TM domains, it is likely that the fusion protein is tethered to 
intracellular or surface membranes of supporting cells. From X-gal staining, it cannot be 
determined whether OTOP1-βGAL is also expressed in hair cells. 
In mice, otoconia formation is completed by P7 (Erway et al., 1986; James et al., 
1969). Although in the adult otoconia do not continue to grow, there remains a slow 
turnover of calcium ions (Balsamo et al., 2000; Preston et al., 1975). This suggests that 
homeostatic mechanisms function to maintain otoconia mineralization. To determine 
whether OTOP1 could function in otoconia maintenance, OTOP1βGAL expression was 
examined in older animals. Inner ear sections from P7 and 6-month-old mice (Figure 2G, 
H) showed that Otop1 continues to be expressed in the supporting and transitional 
epithelium of the utricle and saccule. To confirm expression in adult mice, endogenous 
Otop1 mRNA was detected by quantitative RT-PCR from P2 and 6-month-old utricle and 
saccule. Consistent with the βGAL activity, both P2 and 6 month-old tissues showed 
specific expression of Otop1 in the utricle and saccule but no expression in the cochlea or 
lung (Figure 2I).  
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OTOP1 is localized to the apex of supporting cells. 
Otoconia are formed within the gelatinous membrane above the utricle and 
saccule sensory epithelia. We hypothesized that OTOP1 protein would be localized at a 
subcellular site consistent with a role in the biosynthesis and/or maintenance of otoconia. 
Polyclonal antibodies, generated to an epitope located in the amino terminal domain of 
OTOP1 (Figure 1C), were validated by comparing immunohistochemical staining 
patterns on Otop1+/+ and Otop1βgal/βgal maculae. In Otop1+/+ maculae, endogenous 
OTOP1 was localized at the apical membrane of the epithelium (Figure 3A, C). In 
addition, some signals were also present in a punctate pattern throughout the cell body, 
suggesting possible trafficking of OTOP1 to the apex. In Otop1βgal embryos, the epitope 
recognized by the antibody is tethered to βGAL (Figure 1C). In Otop1βgal/βgal maculae, 
immunohistochemistry showed co-localization of anti-OTOP1 and anti-βGAL signals in 
intracellular aggregates (Figure 3D, E, F). OTOP1βGAL signals were more intense than 
those of the endogenous protein, possibly because the fusion protein forms stable 
aggregates associated with intracellular membranes, owing to the fused TM domains 
(Figure 3A, D).    
Immunostaining of frozen sections and wholemounts of the utricle and saccule 
with the anti-OTOP1 antibody was used to identify cell-specific expression of the 
endogenous OTOP1 protein. Stacked confocal images (Figure 3G) confirmed that anti-
OTOP1 signals were localized towards the apex, just beneath the phalloidin signal, which 
marks the stereocilia bundles of the hair cells. Restricted expression of OTOP1 in 
supporting cells was demonstrated in both Otop1+/+ frozen sections and wholemounts. 
High intensity apical staining was absent above hair cell nuclei but present above 
supporting cell nuclei (Figure 3H, lines), and the cells beneath the stereocilia (marked by 
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phalloidin staining) were all negative for OTOP1 (Figure 3I, J). Absence of expression of 
OTOP1 in the hair cells was also shown by lack of co-localization of OTOP1βGAL with 
the hair cell marker, α-parvalbumin (Figure 3K, L).  
OTOP1 expression alters the purinergic response in chick utricular epithelial cells.  
Previous in vitro studies (Hughes et al., 2007) identified a potential role for Otop1 
in modulating cytosolic free calcium ion concentration ([Ca2+]i) in response to purinergic 
signals, such as ATP. Because endolymph is known to contain ATP and purinergic 
receptors have been identified in several cell types within the inner ear (Housley, 2000; 
Lee and Marcus, 2008), we hypothesized that OTOP1 may also function to regulate 
purinergic signaling in vestibular supporting cells. Primary chick utricular epithelial cells 
(Figure 4A) proliferate in vitro and express markers consistent with a supporting cell 
phenotype (Coutinho et al., 1999; Goodyear and Richardson, 2002; Kruger et al., 1999). 
Quantitative RT-PCR detected Otop1 expression in acutely dissociated cells (Figure 4B). 
However, after seven days in vitro (DIV), expression of Otop1 was reduced to a minimal 
level. This system allowed us to compare the effects of Otop1 expression in primary 
vestibular supporting cells to previous studies using heterologous cells (Hughes et al., 
2007). To test whether 7 DIV primary chick utricular epithelial cells respond to a 
purinergic stimulus, cells loaded with the ratiometric Ca2+ indicator, fura-2, were imaged 
to detect changes in single cell cytosolic free Ca2+ concentrations ([Ca2+]i) before, during, 
and after stimulation with 100 µM ATP (Grynkiewicz et al., 1985; Tsien et al., 1985). 
Application of 100 µM ATP resulted in a rapid rise in [Ca2+]i followed by a steep return 
to baseline (Figure 4C). This type of response is typical of purinergic receptors of the 
P2Y family (Carter et al., 1988; Hughes et al., 2007).  
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To determine if OTOP1 could modulate the accumulation of Ca2+ in 7 DIV 
primary chick utricular epithelial cells, changes in [Ca2+]i in response to ATP in cells 
transfected to express cytosolic EGFP, EGFP-tagged Otop1 (EGFP-Otop1), FLAG-
tagged Otop1 (FLAG-Otop1), or native Otop1 were measured. Cells transfected with 
either EGFP-Otop1 (data not shown) or FLAG-Otop1 (co-transfected with cytosolic 
EGFP) responded to ATP with altered characteristics in the duration of [Ca2+]i elevation 
(Figure 4D). Transfection with cytosolic EGFP alone did not significantly alter the 
purinergic response (Figure 4C). In Otop1 expressing cells, the initial characteristic P2Y 
mediated spike in [Ca2+]i was absent and an increase in [Ca2+]i to an elevated plateau was 
observed. Similar results were seen for untagged Otop1 co-transfected with EGFP (data 
not shown), suggesting that the alteration in Ca2+ mobilization is specific to OTOP1 
activity.  
OTOP1 modulates purinergic response in the utricular maculae. 
To determine if endogenous OTOP1 is necessary to regulate a purinergic response 
in the utricular epithelium, organotypic utricular macular cultures from Otop1+/+ and 
Otop1βgal/βgal inner ears were exposed to ATP. [Ca2+]i was examined in multiple areas 
within each organotypic culture (Figure 5A, B, C). In the Otop1+/+ samples, addition of 
100 μM ATP resulted in an increase in [Ca2+]i, characterized by an elevated plateau that 
persisted until removal of the agonist (Figure 5D). The shape of this response curve 
resembled that of Otop1-transfected chick macular epithelial cells (Figure 4D), and the 
globular substance vesicle response to ATP observed by Suzuki et el. (Suzuki et al., 
1997a). In contrast, in Otop1βgal/βgal maculae, the response to ATP resulted in an initial 
increase in [Ca2+]i, forming a peak, followed by a reduction in [Ca2+]i to an elevated 
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plateau (Figure 5D). These observations suggest that OTOP1 functions to partially inhibit 
a purinergic signal in the utricular macula.  
Dissociated cultures from Otop1+/+, Otop1βgal/+, and Otop1βgal/βgal maculae were 
used to further characterize the OTOP1-specific regulation of the purinergic response. 
Attempts to fully dissociate mouse maculae resulted in cultures that contained regions of 
epithelial sheets and clusters of cells that formed globule-like structures (Figure 6A). 
Interestingly, βGAL activity in Otop1βgal/+ or Otop1βgal/βgal cultures was present in cells 
associated with these globule-like structures, and was less often found in the adjacent 
epithelial sheets (Figure 6D). Therefore, the regions near the globule-like structures were 
selected for imaging (Figure 6B, C). The ATP response of organotypic and dissociated 
macular cells were similar in their shape and kinetics (Figure 5D, 6E). Otop1+/+ and 
Otop1βgal/+ maculae showed a similar response to ATP, demonstrating that a single Otop1 
allele is sufficient for OTOP1-specific modulation of the purinergic response. This result 
is consistent with the presence of normal otoconia in Otop1βgal/+ mice (Figure 1G). Cells 
from regions of the cultures that did not express OTOP1 (in Otop1+/+) or OTOP1-βGAL 
(in Otop1βgal/βgal) showed a different response, characterized by a higher initial peak and 
greater rate of decay in [Ca2+]i (Figure 6G, J). Importantly, cells from these regions 
showed identical responses regardless of whether they were derived from Otop1+/+ or 
Otop1βgal/βgal maculae. 
Previous studies showed that the initial peak in response to ATP primarily results 
in the release of inositol-1,4,5-trisphosphate (IP3)-sensitive intracellular stores by 
activation of P2Y receptors (Carter et al., 1988). Therefore, the reduced peak observed in 
Otop1+/+ compared to Otop1βgal/βgal (Figure 6E) suggested that OTOP1 may function in 
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vivo to inhibit P2Y signaling. To examine whether OTOP1 can block P2Y mediated 
calcium release, we tested the response to UTP, a P2Y receptor-specific agonist 
(Burnstock, 2007; Ralevic and Burnstock, 1998) (Figure 6F). Interestingly, the rate of 
decay in response to UTP was greater in both Otop1+/+ and Otop1βgal/βgal experiments 
when compared to the ATP response (Figure 6J). This is likely because UTP does not 
activate P2X receptors, which, through influx of extracellular Ca2+, maintain the plateau 
phase of the response curve. Notably, similar to what was observed with ATP, UTP 
showed a lower peak value in Otop1+/+ compare to Otop1βgal/βgal macular supporting cells, 
indicating inhibition of P2Y receptor-mediated calcium release by OTOP1. Because 
multiple P2X and P2Y receptors with different ligand sensitivities were found to be 
expressed in the dissociated macular culture (Figure 7) we also tested the activity of two 
major purine analogs (ADP and UDP). Significant difference in the peak values were not 
observed following treatment with either ADP or UDP (data not shown). This suggested 
that OTOP1 may preferentially inhibit the function of P2Y receptor subtypes featuring 
high affinity to ATP and UTP, such as P2Y2 and P2Y4 (Dubyak, 2003; Ralevic and 
Burnstock, 1998). Other purinergic receptors expressed in the macular epithelium, that 
are not regulated by OTOP1, may also contribute to the observed increase in  [Ca2+]I in 
response to ADP or UDP. Alternatively, the inhibitory function of Otop1 may require 
ATP and UTP but not ADP or UDP. 
To examine whether purinergic responses observed in Otop1+/+ and Otop1βgal/βgal 
maculae are dependent on intracellular calcium stores, cultures were incubated with bis-
phenol prior to addition of ATP. Bis-phenol induces release of Ca2+ from intracellular 
stores by inhibiting Ca2+ reuptake by intracellular Ca2+ATPases (Brown et al., 1994; 
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Harper et al., 2005). Because a P2Y receptor-mediated increase in [Ca2+]i is dependent on 
intracellular Ca2+ stores, incubation with bis-phenol should uncouple P2Y receptor 
signaling from the release of intracellular Ca2+ stores. In the presence of bis-phenol, 
Otop1+/+ and Otop1βgal/βgal cultures responded to ATP in a similar manner with a peak and 
rate of decay comparable to that of Otop1+/+ in normal media (Figure 6H, J). This is 
consistent with a loss of P2Y receptor response and retained P2X receptor-like response 
in Otop1+/+ and Otop1βgal/βgal cultures in the presence of bis-phenol.  
Previous in vitro studies (Hughes et al., 2007) and the gain-of-function 
experiments in cultured chick macular supporting cells (Figure 4), suggested that OTOP1 
might have a secondary P2X-like function to mediate influx of extracellular Ca2+ in 
response to ATP. To determine whether OTOP1 functions in vivo to mediate influx of 
Ca2+, Otop1+/+ and Otop1βgal/βgal cultures were assayed for changes in [Ca2+]i in response 
to a purinergic stimulus in the absence of extracellular Ca2+. Imaging in “nominally” 
calcium free media (containing 10-20 µM Ca2+, determined with a Ca2+-selective 
electrode and fura-2 fluorimetry) (Figure 6I) or normal media with 10 mM EGTA 
(containing less than 1 nM Ca2+, data not shown) showed a similar response. In both 
Otop1+/+ and Otop1βgal/βgal cultures, the plateau phase, which represents a balance 
between an influx of extracellular Ca2+ and efflux of cytosolic Ca2+ into intracellular 
stores, is greatly reduced. This results in a faster decay of the initial P2Y peak (Figure 6J) 
compared to cultures stimulated with ATP in normal media. Importantly, the difference 
in the initial peak value between Otop1+/+ and Otop1βgal/βgal cultures was no longer 
observed when extracellular Ca2+ was removed. This suggests that the function of OTOP1 
to inhibit P2Y activity is dependent on extracellular Ca2+ (at concentrations higher than 
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that in nominally Ca2+ free media). These data support a model in which OTOP1 inhibits 
P2Y receptor-mediated Ca2+ release in macular epithelial cells in a Ca2+ -dependent 
manner, and allows or induces an extracellular influx of Ca2+ in response to ATP.   
 
Conclusion 
Otop1 is essential for otoconia formation and thus for the normal physiological 
function of the gravity receptor organs in the inner ear. Several missense alleles in Otop1 
have been identified (tilted, mergulhador, backstroke) and all lead to otoconial agenesis 
in the mouse or otolith agenesis in the zebrafish (Hurle et al., 2003; Sollner et al., 2004). 
The biochemical function(s) of OTOP1 are poorly understood and the biochemical 
consequences of these missense mutations are not known. To interpret phenotype in 
relation to the biochemical function of Otop1 alleles requires knowledge of the genetic 
null allele and its phenotype. To this end, we have created a genetic null allele for Otop1, 
tagged with β-galactosidase (Otop1βgal). Homozygous Otop1βgal/βgal mice have otoconial 
agenesis, similar to that seen in tilted and mergulhador mice. 
The Otop1βgal allele permitted a highly sensitive assay to identify spatial and 
temporal patterns of Otop1 expression and to validate an antibody directed against 
OTOP1. Staining whole maculae for β-galactosidase activity revealed several novel 
features of Otop1 expression. Most remarkably, Otop1 is excluded from the striola in 
both the utricle and saccule, while intensely expressed in the remaining regions of the 
maculae. Otoconia size range from 0.5 to 30 μm in mammals, and the striola is known to 
have fewer and smaller otoconia (Lindeman, 1973). Thus, otoconia formed above the site 
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where Otop1 is expressed are likely to be larger in size and number, correlating Otop1 
expression with its proposed role in the regulation of otoconia growth or calcification.   
Staining histological sections of the maculae for β-galactosidase activity and 
immunohistochemical detection of endogenous OTOP1 revealed that OTOP1 is 
expressed in the supporting and a subset of transitional cells of the mouse utricle and 
saccule, but not in hair cells. In contrast, zebrafish Otop1 mRNA was localized to hair 
cells during otolith growth (Sollner et al., 2004). This disparity between mouse and 
zebrafish could reflect differences in the cell types that are critical for otolith and 
otoconia formation. Importantly, it has been shown that hair cells in mice (Bermingham 
et al., 1999; Hughes et al., 2006; Lundberg et al., 2006) and supporting cells in zebrafish 
(Haddon et al., 1999; Hughes et al., 2006; Lundberg et al., 2006) are not required for 
otoconia/otolith formation.  
Otoconia are formed during embryonic and perinatal development and Otop1 is 
expressed throughout this time. Once formed, the initial complement of otoconia is 
thought to last throughout the life of the organism, with only limited amounts of Ca2+ 
turnover (Balsamo et al., 2000; Preston et al., 1975). However, the observation that 
Otop1 expression persists in the adult (mouse) suggests a possible role for OTOP1 in the 
maintenance and/or repair of otoconia. In humans, otoconia are prone to degeneration and 
displacement due to aging, exposure to ototoxic drugs and head trauma, leading to benign 
positional vertigo and progressive loss of balance (House and Honrubia, 2003; Ross et al., 
1976; Welling et al., 1997). It is not known whether, in humans, Otop1 is expressed 
throughout life and whether OTOP1, alone, is necessary to maintain or repair otoconia. 
Analysis of Otop1 expression in human gravity sensing organs could provide a clue as to 
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whether OTOP1 has a conserved role in the maintenance of otoconia in different species. 
It will also be interesting to investigate whether deformation and fragmentation of 
otoconia, a frequent occurrence in old animals (Jang et al., 2006) and humans (Walther 
and Westhofen, 2007), results from diminished expression or activity of OTOP1. 
Previous studies showed that OTOP1 expression in heterologous cells could 
modify the cellular response to purinergic signals resulting in altered concentrations of 
cytosolic Ca2+ (Hughes et al., 2007). To determine whether a similar OTOP1-dependent 
biochemical activity exists in inner ear supporting cells in vivo, we examined OTOP1 
function in primary chick and mouse utricular epithelial cultures. Restoring Otop1 
expression in chick and comparing wild type and Otop1βgal/βgal mouse utricular macular 
epithelial cultures identified distinct functions by which OTOP1 modulates purinergic 
signaling in vivo. Most importantly, we found that endogenous OTOP1 functions to 
inhibit P2Y receptor activity and subsequent release of Ca2+ from intracellular stores in 
response to purinergic stimuli in vivo. This function was closely phenocopied by 
depleting intracellular Ca2+stores by application of bis-phenol, an inhibitor of all 
microsomal Ca2+ ATPases that effectively uncouples Ca2+ release from P2Y signaling 
(Brown et al., 1994; Harper et al., 2005).   
The function of P2Y signaling during otoconia formation is not known. However, 
recent studies have identified a role for P2Y in bone mineralization, and otoconia and 
bone mineralization share a number of common features (Hughes et al., 2006; Orriss et 
al., 2007). In osteoblasts, P2Y2 receptor activation by ATP and UTP functions to inhibit 
mineralization in vitro and P2Y2-/- mice show increased bone mineral density (Hoebertz 
et al., 2002; Orriss et al., 2007). In the inner ear, P2Y receptors are expressed in the 
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sensory epithelium (Figure 7) and nonsensory epithelium (Piazza et al., 2007; Sage and 
Marcus, 2002; Vlajkovic et al., 2007), and could function to inhibit ectopic 
mineralization in the inner ear. Suppressing ectopic mineralization would be an essential 
function because ectopic mineral deposits or otoconia fragments in the semicircular 
canals (cupulolithiasis) is thought to be a major cause of positional vertigo (Hughes et al., 
2006; Marom et al., 2009) and ectopic mineralization in the cochlea could impair 
auditory function. Inhibition of P2Y receptor signaling by OTOP1 in the macular 
epithelium could serve to locally suppress P2Y activity and thus be permissive to 
localized mineralization of otoconia.  
An additional passive mechanism that could prevent ectopic mineralization in the 
inner ear is the very low concentration of Ca2+ ions normally found in endolymph (10-20 
μM) (Anniko, 1980; Salt et al., 1989). However, a consequence of low endolymph [Ca2+] 
is the requirement to locally increase [Ca2+] at the site of otoconia nucleation and growth. 
This could be achieved by nucleating otoconia within Ca2+-rich vesicles released from 
supporting cells and/or by maintaining local high concentrations of calcium in the 
otoconial membrane. The presence of globular substance vesicles (Suzuki et al., 1995, 
1997b), and Ca2+ ATPase activity in the apical end of the supporting cells (Yoshihara et 
al., 1987) support both mechanisms. The observation that endogenous or overexpressed 
OTOP1 induces a P2X receptor-like influx of extracellular Ca2+ suggests a direct role for 
OTOP1 in sequestration or trafficking of Ca2+ in the maculae. OTOP1 could itself 
function as a Ca2+ channel or it may induce activity of other P2X-like channels. It is 
possible that OTOP1 regulated flux of Ca2+ in supporting cells is a prerequisite for locally 
increasing [Ca2+], either directly in the extracellular space of the otoconial membrane or 
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within globular substance vesicles. Notably, the characteristics of the increase in [Ca2+]i 
by OTOP1 was very similar to the atypical purinergic response described by Suzuki et al 
in isolated globular substance vesicles (Suzuki et al., 1997a), suggesting that OTOP1 may 
be responsible for the ATP-mediated increases in intravesicular [Ca2+]i seen in these 
studies. In addition to Otop1, plasma membrane Ca2+-ATPase 2 (PMCA2) is expressed 
on the apical surface of sensory hair cells (Dumont et al., 2001) and PMCA2-/- mice show 
agenesis of otoconia (Kozel et al., 1998). Notably, [Ca2+] is lower in Deafwaddler 
(Pmca2 frameshift mutation) endolymph compared to controls (Wood et al., 2004). Thus, 
both OTOP1 and PMCA2 may cooperate to regulate local concentrations of Ca2+ above 
the macular epithelium. 
To investigate the requirement for extracellular Ca2+ for OTOP1 activity, wild 
type and Otop1βgal/βgal macular epithelial cultures were assayed for purinergic responses 
in “nominally” Ca2+ free media and Ca2+ free media (10 mM EGTA). The [Ca2+] in 
“nominally” Ca2+ free media is similar to the [Ca2+] in the endolymph. The observation 
that OTOP1 could no longer inhibit P2Y function in “nominally” Ca2+ free media (or in 
the presence of 10 mM EGTA) suggests that OTOP1 is very sensitive to [Ca2+] and that 
apically localized OTOP1 could act as a sensor for extracellular [Ca2+] or interact with 
other sensor molecules to form a feedback signal to regulate [Ca2+] above the macular 
sensory epithelium.   
The studies presented here demonstrate that one function of OTOP1 is to 
modulate purinergic signaling in macular supporting cells. This raises the important 
question of the role of ATP in endolymph. ATP is thought to be stored and released from 
vesicles in the marginal cells of the stria vascularis. In the vestibular system non-sensory 
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epithelium, dark cells (which are functionally similar to strial marginal cells) are a 
possible source of ATP (Lee and Marcus, 2008). Because OTOP1 responds to ATP in a 
dose-dependent manner (Hughes et al., 2007), it may serve as an apical sensor of local 
ATP concentrations. For example, during otoconia formation, release of ATP containing 
vesicles might increase and maintain active OTOP1 and active otoconial growth. 
Alternatively, ATP may function to activate purinergic receptors throughout the inner ear 
(to suppress ectopic mineralization) and through OTOP1 activity, permit mineralization 
in the otoconial membrane. Lastly, it remains possible that the OTOP1 response to 
purinergic signals and the modulation of cellular or extracellular Ca2+ may not be the 
central role for OTOP1 during otoconia formation. For example, in zebrafish, OTOP1 
was shown to regulate the trafficking of starmaker, a protein required for otolith 
formation (Sollner et al., 2004).   
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Figure 1. Targeting the Otopetrin 1 (Otop1) gene. (A) Otop1 spans over 28 kb of 
genomic DNA on mouse chromosome 5 and contains seven exons. (B) Otop1a coding 
sequence starts within exon 2 and is the major splice form of Otop1. Otop1b and 1c are 
transcribed from exon 1 and splice to different sites in exon 2. In the targeting vector, the 
β-galactosidase (βgal) gene and LoxP-neo cassette was inserted in frame to exon 2 after 
the Otop1c slice site. (C) The targeted allele, Otop1βgal, created a fusion protein with the 
first two transmembrane (TM) domains of OTOP1 at the N-terminus of βGal. The 
epitope to which OTOP1 antibody was made is located within the N-terminal tail (red 
line, arrow). (D) Southern blot digested with EcoRV. The wild type allele produces a 17 
kb fragment with both 5’ and 3’ probes. Targeted allele produces a 5’ 8 kb and 3’ 9 kb 
restriction fragment. (E) PCR genotyping with primers shown in panel C. Wild type 
allele, 545 bp; Targeted allele, 369 bp. (F-H) Histological sections through the utricle and 
saccule. (F,G) Otoconia are normally formed above the sensory epithelia (SE) of 
Otop1+/+ and Otop1βgal/+ utricle (upper) and saccule (lower). (H) no otoconia are observed 
in Otop1βgal/βgal otolithic organs. Scale bar, 100 μm.  
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Figure 2. Spatial and temporal expression of OTOP1βGAL. (A) At E13.5 X-gal staining 
is observed in the utricle of Otop1βgal/+ inner ears. (B) At E16.5 both the utricle and 
saccule are positive for βGAL activity. No staining was observed in the cochlea or 
semicircular canals. (C-E) X-gal stained whole mounts of P0 maculae of the utricle and 
saccule. OTOP1βGAL expression is absent from the striola region (S) in the utricle (C) and 
saccule (E). (D) High magnification of the boxed region in (C) showing OTOP1βGAL 
expression in some transitional cells (region below the white dotted line). (F-H) 
Histological sections through the maculae of the utricle. (F) At P0, OTOP1βGAL is 
expressed in supporting cells (black arrowheads) and transitional cells (white 
arrowheads). Similar expression patterns are maintained in P7 (G) and adult (H) mice. (I) 
Quantitative RT-PCR showing endogenous Otop1 expression in P2 utricle/saccule and 
adult inner ear. Error bars are standard deviations of three replicates. Scale bars in C, E, 
100 μm; D, F, G, H, 20 μm. 
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Figure 3. OTOP1 is localized at the apex of supporting cells. (A-F) Frozen sections 
stained with antibodies against the OTOP1 5’ epitope (red) and βGAL (green). (A-C) 
Otop1+/+ utricle showing endogenous OTOP1 localization near the apical sensory 
epithelium. (D) Otop1βgal/βgal utricle showing OTOP1βGAL expression in an intracellular 
vesiclular pattern. (E) The staining pattern with an anti-βGAL antibody matches that of 
the anti-OTOP1 antibody, confirming the specificity of the OTOP1 antibody. (G) 
Confocal image of a wholemount wild type utricle, stacked in the XY plane, showing 
OTOP1 (green) localization just beneath the stereocilia (phalloidin staining, red). (H) 
Frozen section of an Otop1+/+ utricle showing apical staining above supporting cells (SC)  
and no apical staining above hair cells (HC) (red bars). (I, J) Z-stacked image of a 
wholemount utricle showing absence of staining in regions beneath the stereocilia (star). 
(K, L) OTOP1βGAL protein does not colocalize with the hair cell-specific marker α-
parvalbumin. Scale bars, 20 μm. 
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Figure 4. Otop1 regulation of the purinergic response in primary chick utricular 
macular cultures. (A) Bright field image of a chick utricular macular culture after 7 days 
in culture. (B) Expression of Otop1 was assayed in 1 and 7 DIV chick utricular macular 
cultures (n=2 cultures). After 7 DIV, Otop1 expression is no longer detectable (p<0.005). 
(C,D) Transfection of 7 DIV cells to express EGFP and Flag-OTOP1. (C) Wild type 
(WT) (n=16) and EGFP transfected cells (n=11) show similar responses to 200 μM ATP, 
characterized by a sharp increase in [Ca2+]i and rapid return to prestimulation baseline 
before removal of ATP (wash). (D) Compared to untransfected control (n=11), 
transfected cells expressing EGFP and Flag-OTOP1 (n=5) respond to ATP with an 
increase in [Ca2+]i to an elevated plateau that persists until removal of the agonist (wash). 
The data shown here is representative of at least three independent experiments. 
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Figure 5. Purinergic response of organotypic macular cultures from the utricle of 
P0-P3 mice. (A) Bright field image of a utricular macula in culture for 24 hr. Scale bar, 
200μm. (B) Ratio (340/380) image of a culture loaded with fura-2 before stimulation with 
ATP. Circles show areas selected for analysis. (C) Addition of 100 μM ATP results in an 
increase in [Ca2+]i as indicated by change in color (red: high, purple: low). (D) Otop1+/+ 
(n=2) responded to ATP with an increase in [Ca2+]i to an elevated plateau, whereas 
Otop1βgal/ βgal (n=4) maculae showed a biphasic response to 100 μM ATP characterized 
by a sharp peak in [Ca2+]i and a rapid reduction in [Ca2+]i to an elevated plateau. [Ca2+]i 
returned to baseline after removal of agonist (wash). The data shown here is 
representative of four independent experiments. 
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Figure 6. Purinergic response of dissociated macular cultures from the utricles of 
P0-P3 mice. (A) Bright field view of a dissociated utricular epithelial cells after 24 hr in 
culture. Note regions of flattened epithelial-like cells (*) and clumps of cells associated 
with globule-like structures (arrow). Scale bar, 50 μm. (B) Ratio (340/380) image of a 
culture loaded with fura-2. Circles show areas selected for analysis. (C) Addition of 100 
μM ATP results in an increase in [Ca2+]i as indicated by change in color (red: high, 
purple: low). (D) Otop1 expressing cells, identified in heterozygous and homozygous 
cultures (marked by X-gal staining), are predominantly associated with globule-like 
structures (arrow). These cultures also contain Otop1 negative regions (*). (E) Otop1+/+ 
(n=57) and Otop1βgal/+ (n=31) cultures respond to 100 μM ATP by increasing [Ca2+]i to 
an elevated plateau. Otop1βgal/ βgal (n=36) cultures respond to 100 μM ATP by increasing 
[Ca2+]i to an elevated peak followed by a faster rate of decay compared to the Otop1+/+ 
cells. (F) Dissociated cultures stimulated with P2Y receptor-specific agonist UTP 
showing an increased rate of decay (UTP should not activate P2X receptors) in all 
genotypes. Note that Otop1+/+ (n=18) and Otop1βgal/+ (n=43) cultured cells still show a 
decreased peak compared to the Otop1βgal/ βgal (n=26) cultures. (G) Cultured macular 
epithelial cells which do not normally express OTOP1 (negative for βGal activity and not 
associated with globule-like structures) (Otop1+/+ (n=15), Otop1βgal/ βgal (n=12)) show a 
biphasic response to 100 μM ATP with a sharp peak with a fast decay to an elevated 
plateau which persists until wash. (H) Cultures were treated with 40 μM bis-phenol 
(arrowhead) to release Ca2+ from intracellular stores. After incubation with bis-phenol, 
Otop1+/+ (n=13) and Otop1βgal/ βgal (n=20) cultures no longer showed differences in peak 
and rate of decay in response to 100 μM ATP. (I) In nominally Ca2+ free media, Otop1+/+ 
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(n=49) and Otop1βgal/ βgal (n=50) cultures show a similar response to 100 μM ATP with a 
distinct peak and increased rate of decay compared to normal media (E). Note that the 
difference in initial peak value observed in normal media (E) is lost in the absence of 
extracellular Ca2+. (J) Comparison of rates of decay of Otop1+/+ and Otop1βgal/ βgal 
cultures in different experimental conditions. *, p < 0.05; **, p < 0.02.  The data in E-J 
are the combined results of at least three independent experiments.  
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Figure 7. Semi-quantitative RT-PCR analysis of P2X and P2Y receptors in Otop1+/+ 
mouse dissociated culture cells. Expected size of each PCR product is shown below the 
bands. β–actin was used as an endogenous control. P2X2, P2X5, P2X7, P2Y1, P2Y2, 
P2Y4, P2Y6, P2Y12, P2Y13, P2Y14 are expressed. +, with reverse transcriptase (RT); -, 
without RT. 
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Introduction 
 Otopetrin 1 (Otop1) is a member of a new gene family and previous studies have 
shown that OTOP1 is required for formation of normal otoconia, the calcium carbonate 
crystals present in the utricle and saccule (Hurle et al., 2003). The observation that Otop1 
is found in all vertebrates and is phylogenically conserved suggests that OTOP1 has a 
conserved role in biomineralization in vertebrates (Hughes et al., 2008). Ideal for its 
putative function, Otop1 mRNA is expressed in the mouse sensory epithelium (macula) 
of the utricle and saccule (Hurle et al., 2003). Since OTOP1 is predicted to encode a 12-
transmembrane (TM) protein (Hughes et al., 2008), OTOP1, synthesized in the macula, 
may be trafficked to the apex of the epithelium and ultimately interact with proteins in 
the endolymph (the extracellular fluid filling the inner ear labyrinth) to induce or allow 
formation of the crystals. 
 Each otoconium is composed of a proteinaceous core surrounded by calcium 
carbonate crystals. Proteins forming the proteinaceous core (Thalmann et al., 2006) and 
the enzyme catalyzing formation of carbonate ions are known (Hughes et al., 2006; Lim 
et al., 1983; Shiao et al., 2005), but little information is available on the genes important 
for modulating calcium ions during otoconia formation. 
Notably, Suzuki et al (Suzuki et al., 1997) observed that when isolated guinea pig 
globular substance vesicles (putative precursor of otoconia) were stimulated with ATP 
(abundant in endolymph), there was a 5-6 fold increase in intravesicular Ca2+, suggesting 
a possible mechanism by which an increase in [Ca2+] could occur and possibly be 
maintained during the mineralization process. This result also indicated that a protein or a 
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protein complex, with the ability to modulate Ca2+, may be localized within the globular 
substance vesicles, and OTOP1 could potentially be a candidate.    
 Indeed, when OTOP1 was transfected to heterologous systems and tested for 
response to ATP, a similar rise in [Ca2+]i was observed as in the study with globular 
substance vesicles (Hughes et al., 2007). Further studies revealed that OTOP1 can 
specifically modulate purinergic signaling in vitro.   
Quintessential to fully understanding how OTOP1 functions in the biosynthesis of 
otoconia is to understand the mechanism(s) by which OTOP1 function is altered or 
disrupted by mutations that result in non-syndromic failure to form otoconia. Mutant 
alleles of Otop1 (Hurle et al., 2003), tilted (tlt) and mergulhador (mlh) cause a balance 
problem in mice with 100% penetrance due to otoconia agenesis with no other 
abnormalities in the inner ear. Both mutants carry single missense mutations leading to 
non-conservative amino acid substitutions that affect two putative TM (tlt, Ala151->Glu in 
TM3; mlh, Leu408->Gln in TM9) domains. The TM domains bearing the tlt and mlh 
mutations are part of the highly conserved domains (Otopetrin Domain-I, II and III (OD-I, 
II, and III)) found in all the homologues of Otop1 (Hughes et al., 2008), which could be 
functional domains. Investigating how these mutations affect normal expression and 
biochemical functions (especially modulation of purinergic signaling (Hughes et al., 
2007)) may also reveal the function(s) of the highly conserved domains of OTOP1. The 
tlt and mlh mutations are predicted to alter the hydrophobicity of the putative 
transmembrane domains, suggesting that the mutations may alter protein topology, 
membrane trafficking, or biochemical activity. 
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Materials and Methods 
Construction of Otop1tlt and Otop1mlh expression vector 
The full length cDNA clone of Otopetrin 1 (A530025J20) was obtained from 
Riken Laboratories (Japan). To make an N-terminal EGFP fusion constructs of Otop1 
with pCS2EGFP vector, EcoRI and XbaI enzyme linker sites were added by PCR. Due to 
the G-C rich region in the N-terminal loop, a short linker region consisting of the amino 
acids DWK (found in the 3’UTR just upstream of the Otop1 transcription start site) was 
added. The following primers were used to clone EGFPOtop1; primer 1 (5’- 
TTTGAATTCAGACTGGAAGATGCCTGG -3’ (forward)), primer 2 (5’- 
CCCTCTAGACTAGATCTTACAATAGACCTCAAAGAGG -3’ (reverse)). 25 cycles 
of denaturation at 92°C for 30 sec, annealing at 62°C for 30 sec, and extension at 68°C 
for 30 sec were used to amplify 1800 bp fragments. pCS2EGFP empty vector was used as 
a cytosolic EGFP control in all of the following experiments. To construct Otop1tlt and 
Otop1mlh expression vectors, PCR-based site-directed mutagenesis was performed to 
induce these mutations in EGFPOtop1 constructs. Primers used to induce tlt and mlh 
mutations were as follows; tlt, primer 1 (5’- 
ATGAAGTATTCGACTTTCAAGCATCCCAGGACG -3’ (reverse)), primer 2 (5’- 
AAAGTCGAATACTTCATTGGATTCTCGGAGTGC -3’ (forward)), mlh, primer 1 (5’- 
ATGGCCTGAATGGAGCCCCAGGAGAGG -3’ (reverse)), primer 2 (5’- 
TCCATTCAGGCCATCGCCTGTGCTGAG -3’ (forward)).  25 cycles of denaturation at 
94°C for 1 min, annealing at 63°C for 1 min, and extension at 72°C for 2 min were used 
to amplify each mutant forms. 
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Cell culture and transfection 
COS7 cells were maintained in Dulbecco’s Modified Eagle Media (Gibco) 
supplemented with 10% fetal calf serum (Gibco), 2mM L-glutamine, and 1X 
penicillin/streptomycin. Cells were plated on 35 mm plates with glass coverslips (MatTek 
Cultureware) 24-48 hours before transfection. Cells were transfected using Lipofectamine 
2000 (Invitrogen) and approximately 1 μg plasmid DNA in OptiMEM (Invitrogen) for 4-
5 hours following manufacturer’s instructions. Cultures were allowed to recover 
overnight in growth media.  
 
Preparation of mouse utricular macular dissociated culture 
P0-P3 utricles were dissected in medium 199 (Gibco #12350039), and the 
nonsensory epithelium and otoconial layer were completely removed. After incubation in 
thermolysin (Sigma) at 37°C for 50 min, the underlying stroma was removed and the 
remaining epithelial sheet was attached to a MatTek dish using ECM gel (Sigma). The 
tissue was incubated in growth media overnight at 37°C. For dissociated culture, isolated 
epithelial sheets were treated with Trypsin/EDTA (0.05%, 0.02%) for 15 min at 37 °C. 
After replacing Trypsin/EDTA with Medium 199 (Gibco #12340030) cells were 
triturated 5 to 10 times and plated on laminin coated MatTek dishes and incubated 
overnight at 37°C. The next day Medium 199 (Gibco #12340030) containing 10% fetal 
bovine serum (Gibco) was added. 
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Ratiometric calcium imaging and data analysis  
All imaging experiments were carried out at room temperature in a HEPES-
buffered salt solution (HCSS) containing, in mM: 140 NaCl, 5.4 KCl, 1 NaH2PO4, 1.8 
CaCl2, 1 MgSO4, 12 HEPES, and 5.5 D-glucose, pH 7.4±0.1. COS7 cells or dissociated 
utricular macular cultures were loaded with fura-2 by incubation for 60 min with 5-10 
µM acetoxymethyl (AM) ester (Invitrogen, Eugene, OR) and 0.1% Pluronic F-127 
(Invitrogen, Eugene, OR) in HCSS (pH=7.2) at room temperature, washed with HCSS 
and incubated for another 60 min to allow for ester hydrolysis. After loading, cells were 
imaged on an inverted microscope (Nikon Eclipse TE300, Nikon Inc., Melville, NY) 
equipped with a cooled CCD camera (Cooke Corp., Auburn Hill, MI) using a 20x/0.45 
Plan Fluor objective (Nikon). The fluorescence excitation (75 W xenon arc lamp) was 
provided by band-specific filters (340 and 380 nm; Semrock, Rochester, NY) in 
combination with a XF73 dichroic beam splitter (Omega Optical, Brattleboro, VA). Pairs 
of images were collected constantly at alternate excitation wavelengths. After subtracting 
the matching background, the image intensities were divided by one another to yield ratio 
values for individual cells. Ionomycin was from Calbiochem (San Diego, CA), ATP was 
from Sigma (St. Louis, MO). 
For COS7 cells, fluorescent intensities of GFP (485 nm) and fura-2 (340 and 380 
nm) channels were recorded. Analysis of fura-2 signal intensities in unloaded GFP-
expressing cells showed that approximately 4% and 23% of the GFP signal bleeds 
through 340 and 380 fura-2 channels, respectively. Therefore, the signal intensity 
contributed by the presence of GFP was subtracted from each value before analysis of 
each experiment. Each point was then normalized to the average of the baseline points 
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(before adding an agonist). For studies done with mouse macular dissociated cultures, 10 
μM ionomycin was added at the end of each experiment to obtain the maximum level of 
[Ca2+]i in each region of interest. To make data points comparable between experiments 
performed on different days, raw data (ratio of 340/380 fluorescent intensity) was 
normalized as follows: Normalized Ratio = (R- R0)/(Rmax- R0), where R is the individual 
ratio value, Rmax is the peak ratio after addition of ionomycin, R0 is the average of the 
prestimulation baseline ratio.  
 
Production of anti-Otop1 antibody 
A rabbit polyclonal antibody was made using a 16-amino acid peptide epitope 
(ARGSPQASGPRRGASV) derived from the N-terminus of OTOP1 (Fig 1C). The 
synthetic peptide was conjugated to maleimide-activated keyhole lympet hemocyanin 
prior to injection into the rabbit.  The resulting antibody was purified on the peptide 
affinity column, and validated by Western blotting of extracts from inner ear tissues. 
Further validation was performed in this study by comparing the immunostaining patterns 
with those of X-gal staining. 
 
Wholemount immunohistochemistry  
Temporal bones were isolated in Leibovitz’s medium L15 (Sigma) and fixed in 
4% paraformaldehyde for 1-2hr at RT. Utricular and saccular maculae were dissected 
from the temporal bones in cold PBS, incubated in 0.5% Triton X-100 for 30 min at room 
temperature, and then washed with PBS. Samples were blocked using 4% BSA/PBS 
overnight at 4°C, and incubated with rabbit α-Otop1 (1:800) and/or mouse α-parvalbumin 
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(Sigma- 1:500) for 90 min at room temperature in a humidified chamber.  After washing 
with PBS, samples were incubated with secondary antibodies, Alexa 488 anti-rabbit IgG 
(Invitrogen- 1:600) and Alexa 555 anti-mouse IgG (Invitrogen- 1:600), respectively for 
45 min at room temperature. For stereocilia staining, samples were further incubated with 
rhodamine-phalloidin (Invitrogen- 1:200) for 15 min at room temperature. After washing 
with PBS, samples were transferred to a superfrost slide, mounted with vectashield 
(Vector labs), and coverslipped before imaging with an Olympus FV500a multi-channel 
confocal microscope. 
 
Results 
EGFPOtop1tlt and EGFPOtop1mlh-expressing COS7 cells show a reduced purinergic 
response to ATP. 
The phenotypes of the tlt and mlh mice are the result of single base pair mutations 
in the Otop1 coding region leading to non-conservative amino acid changes in TM5 and 
TM9, respectively (Figure 3A). Both mutations are predicted to alter the hydrophobicity 
of their putative transmembrane domains, suggesting that they may alter the subcellular 
localization of the mutant protein and/or may affect its activity. To assess this possibility, 
COS7 cells were transfected with EGFPOtop1tlt and EGFPOtop1mlh, and their 
localization and response to exogenous ATP was observed. The tagged EGFP protein 
allowed us to effectively mark subcellular localization of the mutant protein in COS7 
cells. Surprisingly, presence of either mutation did not alter the localization of the EGFP 
signal. Wildtype OTOP1 and the mutant proteins were found extensively in the 
endoplasmic reticulum (ER) and a dimmer signal was also positive in the plasma 
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membrane (PM) (Figure 1B, C, D). This is consistent with the fact that OTOP1 does not 
have any known signal peptide (Hurle et al., 2003) with which OTOP1 may have been 
trafficked to other subcellular compartments. Whether Otop1 functions in the ER needs 
to be studied in further detail, but nonspecific localization of overexpressed 
transmembrane domain proteins in the ER have been previously observed (Brostrom and 
Brostrom, 2003; Dellis et al., 2006).  
To test whether OTOP1TLT and OTOP1MLH could respond to purinergic stimuli in 
a similar manner to the wildtype OTOP1, time lapse fluorescence microscopy was used 
to monitor change in cytosolic [Ca2+] in COS7 cells transfected with EGFPOtop1tlt and 
EGFPOtop1mlh after loading with fura-2 acetoxymethyl ester. Untranfected COS7 cells 
(WT) and those transfected with cytosolic EGFP responded to ATP (Figure 2 and data 
not shown) with a rapid peak in [Ca2+]i, which is due to Gαq-coupled P2Y receptor 
signaling (Hughes et al., 2007). Cells expressing EGFPOtop1 showed a dramatic absence 
of this peak in response to ATP. The plateau phase following the initial peak shown in 
the WT cells is mainly mediated by influx of extracellular calcium (Hughes et al., 2007). 
In EGFPOtop1-positive cells, the level of the plateau phase was also reduced compared 
to the WT (Figure 2A). In response to ATP, EGFPOtop1tlt and EGFPOtop1mlh-positive 
cells showed a reduced increase in [Ca2+]i compared to the WT (Figure 2B, C) . However, 
the way the response changed due to expression of the mutant proteins was subtly 
different from the effect seen by expressing EGFPOtop1. The initial peak was more 
apparent (dotted circle) and the level of extracellular Ca2+ influx, depicted in the 
following plateau phase, was slightly higher in mutant expressing cells. These data 
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suggested that the presence of tlt and mlh mutations most likely reduces OTOP1 less 
inhibition of P2Y receptor function.  
 
Tlt and mlh mutations affect trafficking of endogenous OTOP1. 
 It was still possible that the overexpression system may have forced the wildtype 
and mutant proteins to be localized differently from the endogenous OTOP1. Therefore, 
OTOP1 localization was further investigated in P0 Otop1tlt/tlt and Otop1mlh/mlh utricles 
with wholemount immunohistochemistry. A new anti-OTOP1 antibody was generated, 
against an epitope located at the N-terminus of the protein before the first putative TM 
domain (Figure 3A). According to the predicted secondary structure (Hughes et al., 2008), 
this epitope is likely to be located in the cytosol. The specificity of this antibody had been 
previously confirmed by co-localization with βGAL signal in a homozygous null allele of 
Otop1 (Otop1βgal/βgal).  
XY-plane stacked images of the wholemount utricles were obtained after confocal 
imaging to compare the location of OTOP1 signals with respect to the apical and basal 
sides of the macular epithelium. In Otop1+/+, signals were in a punctate pattern, possibly 
due to localization within intracellular vesicles (Figure 3B). Signals were located just 
underneath the apical end (marked by the stereocilia bundles stained with phalloidin); 
almost no signal was detected below the mid region of the epithelium (Figure 3F). 
Because Otop1βgal allele still expresses the first two TM domains we were able to detect 
the localization of the β-galactosidase (βGAL) fusion protein using the Otop1 antibody 
made against the N-terminal epitope. Signal intensity in Otop1βgal/βgal tissue is greatly 
increased (Figure 3C, F); signals were highly localized at the mid region of the 
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epithelium. This suggested that the fusion proteins formed aggregates within the 
intracellular vesicles and could no longer be trafficked to the apical end. OTOP1 signal 
pattern in Otop1tlt/tlt (Figure 3D) and Otop1mlh/mlh (Figure 3E) tissue clearly showed mis-
localization of the mutant proteins. The signals were spread out throughout the 
epithelium in a punctate pattern, and most of them did not reach the apical end (Figure 
3F). These results suggest that both tlt and mlh mutations were sufficient to alter the 
localization of OTOP1 and therefore the TM domains (TM3 and9) and/or the Otopetrin 
Domains (OD-I and II) bearing these mutations might be important for subcellular 
localization of OTOP1. Impaired localization in Otop1tlt/tlt and Otop1mlh/mlh tissue 
suggests the importance of apical localization for the normal function of OTOP1.   
 
Ratiometric Ca2+ imaging with primary cultures of macular epithelial cells. 
 To determine if endogenous OTOP1TLT can alter the in vivo function of OTOP1 in 
modulating purinergic signaling, dissociated macular supporting cell cultures from 
Otop1+/+, Otop1βgal/βgal, Otop1tlt/+, Otop1tlt/tlt inner ears were exposed to 100 μM ATP. In 
the Otop1+/+ samples, addition of ATP resulted in an increase in [Ca2+]i, characterized by 
an elevated plateau that persisted until removal of the agonist (Figure. 4). The shape of 
this response curve resembled that of the globular substance vesicle response to ATP 
observed by Suzuki et el. (Suzuki et al., 1997). In contrast, in Otop1βgal/βgal maculae, the 
response to ATP showed a higher peak, followed by a reduction in [Ca2+]i to an elevated 
plateau. Detailed study on the source of calcium that mediates such an increase in [Ca2+]i 
in mouse dissociated macular cultures showed that the peak represented P2Y receptor-
mediated Ca2+ release from intracellular stores, whereas the plateau phase indicated a 
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balance between an influx of extracellular Ca2+ and efflux of cytosolic Ca2+ into 
intracellular stores. Therefore, the different response to ATP in Otop1+/+ and 
Otop1βgal/βgal cultures suggested that OTOP1 functions to inhibit P2Y function and 
induces/allows influx of extracellular Ca2+.  
 Otop1+/+ and Otop1tlt/+ macular cultures showed a similar response to ATP, 
demonstrating that a single Otop1 allele is sufficient for OTOP1-specific modulation of 
the purinergic response. This result is consistent with the presence of normal otoconia in 
Otop1tlt/+ mice (Ornitz et al., 1998). Interestingly, Otop1tlt/tlt macular cultures also showed 
a similar response to ATP as Otop1+/+ samples, indicating that the tlt mutation does not 
interfere with the function of OTOP1 to modulate purinergic response in macular 
supporting cells. The tlt mutation may primarily influence protein localization (Figure 3B, 
D) or another unknown biochemical function of OTOP1.  
 
Conclusions 
Otopetrin 1 (Otop1) is essential for the formation of otoconia in the otolithic 
organs in the inner as the primary phenotype found in all the mutants of Otop1 is 
otoconial agenesis (Hughes et al., 2004; Hurle et al., 2003; Ornitz et al., 1998; Sollner et 
al., 2004). Tlt and mlh are two mouse mutations in Otop1 caused by single amino acid 
substitutions in the highly conserved putative transmembrane (TM) domains (TM3 for tlt 
and TM9 for mlh) (Hughes et al., 2008; Hurle et al., 2003). Since these mutations are 
predicted to alter the hydrophobicity of different TM domains, which are parts of highly 
conserved but distinct Otopetrin Domains (Hughes et al., 2008), the mechanism by which 
each mutation affects OTOP1 protein function may also be different. To assess this 
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possibility we studied protein localization, and the ability to modulate purinergic 
response in in vitro and in vivo.  
Introduction of the tlt and mlh mutations into the full-length Otop1 construct did 
not significantly alter the localization of the overexpressed protein in COS7 cells. 
However, comparison of the Otop1+/+, Otop1tlt/tlt, and Otop1mlh/mlh utricles revealed that 
the apical localization of endogenous OTOP1 is impaired in both mutant samples, a 
phenotype that could not be assessed in COS7 cells grown in monolayer culture. In terms 
of modulating the purinergic response, the mlh mutation seems to impair OTOP1 
function more than the tlt mutation as we observed less inhibition of P2Y- mediated 
function in EGFPOtop1mlh-expressing COS7 cells compared to EGFPOtop1tlt-expressing 
COS7 cells. Further ratiometric calcium studies with Otop1mlh/mlh macular epithelial cells  
needs to be done to confirm this point. Similar purinergic response in Otop1+/+ and 
Otop1tlt/tlt samples suggests that the tlt mutation impairs localization of the rather 
biochemical function, thus blocking the access of a functional protein. Alternatively, tlt 
mutation may affect other biochemical function(s) of OTOP1 which were not revealed in 
our ratiometric calcium assays. These data suggested that tlt and mlh mutations may 
differentially affect OTOP1 function and define distinct functions of each conserved 
Otopetrin Domain.  
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Figure 1. Localization of EGFPOtop1tlt and EGFPOtop1mlh in COS7 cells. A) EGFP 
is fused throughout the whole cytoplasm. B) EGFPOtop1 predominantly localizes to the 
endoplasmic reticulum (ER) and a fainter signal is detected in the plasma membrane 
(PM). C and D) Presence of tlt or mlh mutations does not affect localization of the 
transfected OTOP1 protein.  
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Figure 2. Overexpression of EGFPOtop1, EGFPOtop1tlt, and EGFPOtop1mlh in 
COS7 cells alters the purinergic response. A) WT (n=26) showed a biphasic response 
to 100 μM ATP with an initial peak followed by a plateau phase which persisted until 
removal of the agonist (wash). The initial peak (rise) in [Ca2+]i was much lower in the 
presence of EGFPOtop1 (n=19) where a sharp peak was absent. B) EGFPOtoptlt-positive 
cells (n=26) showed a reduced initial rise in [Ca2+]i compared to the WT (n=24) cells. 
Presence of the peak was apparent (dotted circle) compared to EGFPOtop1-expressing 
cells (A). C) GFPOtopmlh-positive cells (n=20) showed a biphasic response with a peak 
and a plateau phase, however the overall response was lower than with WT cells (n=20).   
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Figure 3. Apical trafficking of endogenous OTOP1 is affected in Otop1tlt and 
Otop1mlh utricular maculae. A) Schematic diagram showing the location of tlt and mlh 
mutations with respect to the putative transmembrane (TM) domains of OTOP1. Tlt and 
mlh are present within TM 3 and 9, which are parts of Otopetrin Domain I and II, 
respectively. The epitope for the OTOP1 antibody is located N-terminal to the putative 
TM domains. B-E) XY plane-stacked image of wholemount utricles stained with 
phalloidin and the anti-OTOP1 antibody. Phalloidin, shown in red, depicts the stereocilia 
bundles and actins at the apical (A) and basal (B) end, respectively. OTOP1 signals are 
shown in green. B) Wildtype OTOP1 is localized near the apex of the epithelium. C) In 
Otop1βgal/βgal tissue, the β-galactosidase fusion protein is mis-localized and forms 
aggregates with each other possibly in intracellular vesicles. D, E) OTOP1TLT and 
OTOP1MLH are not get properly targeted to the apex and the signal is concentrated in the 
mid to basal end of the epithelium. F) Quantitation of OTOP1 signal intensities with 
respect to its location in the wholemount utricles (shown in B-E). X-axis depicts distance 
from apical to basal end, where ‘0’ indicates the most apical region.  
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Figure 4. Otop1tlt macular culture cells respond to ATP in a similar manner to 
e 
e 
 
Otop1+/+.  In response to 100 μM ATP, OTOP1 inhibits P2Y receptor function, whil
allowing P2X-like influx of Ca2+. This is shown as a reduced peak level compared to 
Otop1βgal/βgal culture cells and a sustained increase in [Ca2+]i until wash. Unlike with th
null allele (Otop1βgal/βgal), the tlt mutation does not disrupt the function of OTOP1 to 
modulate the purinergic response in vivo.   
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Introduction 
minary studies focused on identifying the genetic etiology of otoconial 
agenesi
 
conside top3 being 
ical 
ested that one biochemical function of 
OTOP1
et al., 
timuli 
ch 
In preli
s in tilted (tlt) mutant mice (Hurle et al., 2003), we identified the Otopetrin 1 
(Otop1) gene and its paralogues Otopetrin 2 (Otop2) and Otopetrin 3 (Otop3). Mouse
OTOP2 and OTOP3 show 34% and 30% amino acid identity with OTOP1, respectively. 
These genes express the highly conserved domains (Otopetrin Domain I, II, and III) 
(Hughes et al., 2008), which could be the functional domains of this gene family.   
Otop1 is expressed in many major organs (Hurle et al., 2003). There is 
rable overlap in expression between the three mouse Otopetrins, with O
the most restricted. Overlapping patterns of expression suggests the potential for 
functional redundancy. We hypothesized that all Otopetrins have similar biochem
properties. Additionally, functional redundancy may mask other developmental or 
physiological activities in other organ systems.  
Previous studies with Otop1 mutants sugg
 is very likely related to regulating calcium homeostasis, which could be 
important for calcification during otoconia formation (Hughes et al., 2004; Hurle 
2003; Sollner et al., 2004). In support of this idea, OTOP1 was shown to have a 
prominent role in regulating Ca2+ levels or Ca2+ transit in response to purinergic s
in heterologous systems (Hughes et al., 2007). Purinergic signaling is mediated by two 
classes of P2 receptors, P2Y and P2X receptors, which have distinct pharmacological 
responses to purines and purine analogs (North and Surprenant, 2000; Ralevic and 
Burnstock, 1998). P2Y receptors are metabotropic G-protein coupled receptors whi
mediate release of intracellular Ca2+ stores, whereas P2X receptors are ionotropic 
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channels which allow influx of extracellular Ca2+ upon ATP binding. Overexpress
EGFP-Otop1 in COS7 cells had three prominent consequences: 1) nonspecific depletion 
of endoplasmic reticulum calcium stores, 2) specific inhibition of the purinergic receptor 
P2Y2, and 3) initiation of a novel influx of extracellular calcium in response to ATP-like 
nucleotides. In a physiological setting, these activities could direct the formation and 
growth of otoconia and regulate other biomineralization processes. Investigating whet
OTOP2 and OTOP3 share such biochemical functions of OTOP1 in modulating [Ca2+]i 
will help us understand the redundancy between mouse Otopetrins .  
To fully understand the in vivo role of a protein generation of its null a
ion of 
her 
llele is 
indispe ill 
 
further 
 
nsable. In this study, we generated a null allele of Otop2 (Otop2nβgal), which w
consequently allow us to determine whether it has unique biological functions by looking
for phenotypes in Otop2nβgal/nβgal mice. The highly conserved expression of Otop2 in the 
digestive tract of mouse and other animals (chicken, cow, fish) suggests that this will be 
an important site to look for a secretion or absorption phenotype in Otop2nβgal/nβgal mice. 
Generation of an Otop1/Otop2 double null mouse will allow potential functional 
redundancy between these two genes to be examined in mouse development. The 
findings from Otop2nβgal/nβgal mice and double homozygous null mice may suggest 
biochemical activities. 
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Materials and Methods 
llele 
as made using recombineering methods (Liu et al., 
2003). ed 
2 
wo 
that 
 
protein ctor 
Generation of Otop2nlacZ a
The targeting construct w
First, about 5 kb upstream and downstream of the regions to target was retriev
from BAC clone RP23-117K15 (derived from C57BL/J6 mice), which completely 
spanned the Otop2 gene. We designed a deletion of most of exon 2 (306 bp), intron 
(837 bp), exon 3 and a portion of intron 3 (651 bp). β-galactosidase (βgal) gene and 
LoxP/pol-2-neo/LoxP selectable marker (6.1 kb) were ligated in-frame with the first t
amino acids of exon 2. The SV40 nuclear transport signal (Lanford et al., 1988) was 
added at the N-terminus of the β-galactosidase gene to target lacZ expression to the 
nucleus (nlacZ). To achieve this, 500 bp sequences immediately 5’ and 3’ of the site 
we aimed to target was ligated to the βgal coding sequence and the neo cassette, which 
was excised from the PL452 vector and cloned into a pBluescript vector. This construct 
was electroporated into DY380 cells already containing the retrieved BAC plasmid, and 
heat shock (32°C -> 42°C) was used to induce homologous recombination to generate the
targeting vector. The 5' and 3' regions of homology contained a total of 7.6 kb of genomic 
DNA. The targeting vector was verified by restriction mapping and sequencing.  
Before electroporation, the integrity and function of the OTOP2nβGAL fusion 
 was tested in tissue culture cells. The Otop2-nβgal portion of the targeting ve
was transiently expressed using lipofectamine (Invitrogen) in COS7 cells under a CMV 
promoter and cells were stained for βgal activity. OTOP2nβGAL positive cells showed X-
gal staining consistent with nuclear localization of the chimeric protein.  
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The targeting construct was linearized and electroporated into SCC-10 ES cells, 
which were derived from 129X1/SvJ mice. Electroporation was carried out in the 
Washington University Siteman Cancer Center Murine Embryonic Stem Cell Core 
facility. G418 resistant clones were screened for homologous recombination by Southern 
blot using 5’ probes. Two positive clones were identified and homologous recombination 
was verified using a 3’ Southern blot probe. ES clones were karyotyped and then 
microinjected into mouse blastocysts by the Washington University Mouse Genetics Core 
facility. Chimerism was determined by coat color and high percentage chimeric males 
were mated with C57BL6/J females. The subsequent F1 mice were intercrossed, and the 
litters were examined for the germline transmission of the Otop2nβgal allele using 
Southern blotting with 5’ and 3’ probes extrinsic to the targeting vector and by genomic 
PCR (Figure 1). The LoxP-neo cassette was excised in vivo by mating to a mouse that 
expressed Cre in the germ line, and then the male progeny were bred to C57BL6/J 
females to transfer the targeted allele onto a C57BL6/J genetic background.  
 
Southern blotting and genomic PCR 
Genomic DNA was extracted with phenol/choloroform and isopropanol 
precipitation. 10 μg of each sample was digested with either BamHI (5’ probe) or Asp718 
(3’ probe) at 37°C overnight and electrophoresed on 1% agarose gel. Southern blots were 
probed with 5’ and 3’ probes, which were labeled with 32P (Stratagene Prime-It II 
Random Primer Labeling Kit) and purified (Amersham Biosicences MicroSpin S-200 HR 
columns). 5’ and 3’ probes were made by amplification from RP23-117K15 BAC DNA 
with the following primers: 5’ probe: primer 1 (5’- CTTGAGCCACATTGGCCCCT 
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- 3’ (forward)), primer 2 (5’ - GGCCAGATGCTGTGACCCTC 
- 3’ (reverse)), 3’ probe: primer 1 (5’ – TCTATCGTGGCTGTGGTGGTG 
- 3’ (forward)), primer 2 (5’ - TATGAGGGCTTCTGCTTGGG 
- 3’ (reverse)). For genotyping PCR, mouse tail DNA was amplified with the following 
primers: primer 1 (5’- GACTTAGAATCCTGTCCTTGCCCC 
-3’ (forward)), primer 2 (5’- TTTGCTCTTCCTTCCCAGGGC 
-3’ (wild-type reverse)), primer 3 (5’- TCTGCCAGTTTGAGGGGACGA -3’ (Otop2nβgal 
reverse)). 30 cycles of denaturation at 94°C for 1 min, annealing at 65°C for 1 min, and 
extension at 68°C for 3 min were used to amplify either 527 (wild-type) or 380 
(Otop2nβgal) bp fragments. 
 
Construction of Otop2 and Otop3 expression vector 
The full length cDNA clone of Otop2 (4732464P15 or AK028866) and Otop3 
(A730078K24 or AK043266) was obtained from Riken Laboratories (Japan). To clone 
Otop2 and 3 into the pCS2EGFP vector, which makes N-terminal EGFP fusion 
constructs, EcoRI (forward) and XbaI (reverse) enzyme linker sites were added with PCR. 
The following primers were used to clone EGFPOtop2: primer 1 (5’- 
TTTGAATTCAATGTCGGAGGAACTGGT -3’ (forward)), primer 2 (5’- 
CCCTCTAGATCTCTGTGGAGCTTCAGG -3’ (reverse)). The following primers were 
used to clone EGFPOtop3: primer 1 (5’- TTTGAATTCAATGGCTTCGCAGACTTC -3’ 
(forward)), primer 2 (5’- CCCTCTAGATCAGGCCCCCAGGTA -3’ (reverse)). 25 
cycles of denaturation at 92°C for 30 sec, annealing at 62°C for 30 sec, and extension at 
68°C for 30 sec were used to amplify either 1692 (Otop2) or 1790 (Otop3) bp fragments. 
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Cell culture and transfection 
COS7 cells were maintained in Dulbecco’s Modified Eagle Media (Gibco) 
supplemented with 10% fetal calf serum (Gibco), 2mM L-glutamine, and 1X 
penicillin/streptomycin. Cells were plated on 35 mm plates with glass coverslips (MatTek 
Cultureware) 24-48 hours before transfection. Cells were transfected using Lipofectamine 
2000 (Invitrogen) and approximately 1 μg plasmid DNA in OptiMEM (Invitrogen) for 4-
5 hours following manufacturer’s instructions. Cultures were allowed to recover 
overnight in growth media.  
 
Ratiometric calcium imaging  
Transfected cells were loaded with the Ca2+ sensitive dye Fura 2 acetoxymethyl 
ester (Invitrogen) for 35 min at 37°C in 5% CO2 following manufacturer's instructions to 
examine stimulus-dependent alterations in cytosolic Ca2+ concentrations, [Ca2+]i (5). 
Cells were then washed in growth media for 30 min, equilibrated to physiologic 
recording media (145 mM NaCl/5 mM KCl/1.8 mM CaCl2/1 mM MgCl2/10 mM 
Hepes/10 mM glucose, adjusted to pH 7.38-7.44 with 10 N NaOH) for 15 min and 
washed twice in recording media before analysis. Ca2+-free media contained 3 mM 
EGTA. For sodium-free media, NaCl was replaced isotonically with N-methyl-D-
glucamine and the pH adjusted to 7.4 with HCl. For chloride-free media, chloride was 
isotonically replaced with gluconate salts, except MgCl2 was replaced with MgSO4. 
Cultures were examined with a Zeiss Axiovert (Carl Zeiss, Thornwood, NY) 
inverted microscope at room temperature and images were captured with an Intelligent 
Imaging Innovations digital camera system and analyzed with Slidebook software 
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(Intelligent Imaging Innovations, Denver, CO). Images of EGFP and Fura 510-nm 
emission after excitation at 340 nm and 380 nm, respectively, were taken sequentially at 
10-s intervals. Dye fluorescence intensity was collected and then measured on a pixel-to-
pixel basis to yield a single bitmap field. Images were collected with 8´ binning. Cellular 
fluorescence was defined by measurement windows placed over individual cells. Average 
pixel fluorescence over the measurement field, which included ER and nucleus, was 
calculated by the imaging software and then logged to a file. The values for single-cell 
emission (at 510 nm) ratio (F340/F380 ratio = emission at 340 nm excitation/emission at 
380 excitation) were plotted over time.  
All cultures were examined in 1 ml of recording media. Agonist was added by 
pipette to the static bath media. Washes were continuous with full replacement of the 
media. Pharmacologic agents were added to aliquots of recording media before 
administration to cells. Cells were observed for 1-2 min before addition of pharmacologic 
agents to assess stability of the baseline. Untreated media was removed and rapidly 
replaced with treated media. Cells were examined throughout the pretreatment period and 
treated with agonist as above. Vehicle controls were identical to untreated in all 
experiments. ATP, ADP, UTP, UDP, ATPγS, methyl-S-ATP, αβ-methyl-ATP were 
obtained from Sigma (St. Louis, MO). 
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Results 
Otopetrin 2 (Otop2) null allele was successfully generated. 
The Otop2 gene covers over 25 kb of genomic DNA on mouse chromosome 11 
and is divided into seven exons. The coding sequence begins in exon 2 (exon 1 is in the 
5’ untranslated region) and only one coding (and two non-coding) splice form of Otop2 
has been identified (Hurle et al., 2003) (Figure 1A).  To generate a null allele for Otop2 
and to create a histochemical tag to identify Otop2-expressing cells, the Otop2 gene was 
targeted by insertion of a β-galactosidase gene in-frame with exon 2 after the first two 
amino acids (Figure 1A). A nuclear transport signal (Lanford et al., 1988) was added at 
the N-terminus of the β-galactosidase gene to target the fusion protein (nβGAL) to the 
nucleus. This design expressed Otop2nβgal transcript under the control of Otop2 
transcriptional regulatory elements.  
 There are two genes located in the immediate vicinity of Otop2: Ush1g and Otop3 
(Figure 1B). The first intron of the Otop2 gene contains the Ush1g gene, which is thought 
to be responsible for Usher syndrome type 1G (USH1G) in humans and in mice, the 
Jackson shaker (js) congenital sensorineural deafness, constant vestibular dysfunction, 
and retinitis pigmentosa with prepubertal onset syndrome. Given the close association 
with these neighboring genes, targeting Otop2 could affect the expression of these genes. 
Therefore, the Otop2 targeting vector was designed to remove a minimum amount of 
intron sequence while still ensuring a complete inactivation of Otop2. Importantly, 
genomic sequence analysis of the intronic regions deleted in Otop2 showed no conserved 
sequence in the rat, human, dog, and chicken orthologous regions. Because the inserted 
PKG-Neo gene (Figure 1A) could also affect expression of neighboring genes, it was 
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removed by mating with germ-line expressed Cre recombinase before analyzing the 
phenotype. 
The germ-line transmitted targeted allele was confirmed by Southern blotting 
(Figure 1C) and genomic PCR (Figure. 1D). Heterozygous (Otop2nβgal/+) and 
homozygous (Otop2nβgal/nβgal) mice were phenotypically normal. The otoconia and the 
underlying sensory epithelium were also intact, suggesting that OTOP2 has a less 
important role in the formation of otoconia compared to OTOP1 and/or the redundancy 
with other paralogues could be masking the function of OTOP2. This observation led us 
to generate double knockout mice for Otop1 and Otop2. Unfortunately, there has been no 
apparent phenotype in the double knockout mice either, other than otoconial agenesis, 
which is most likely resulting from knocking out Otop1. X-gal staining was not positive 
in E16.5 or P0 inner ear, including the utricle and saccule, suggesting that endogenous 
OTOP2 may not be expressed in the inner ear. Future studies will involve investigating 
sites of Otop2 expression and potential associated phenotypes.  
 
EGFPOtop2 and EGFPOtop3 expressing COS7 cells respond to different purinergic 
agonists.  
 Previously, OTOP1 was shown to have the ability to modulate [Ca2+]i in vitro 
(Hughes et al., 2007). Since OTOP2 and OTOP3 also contain the conserved Otopetrin 
Domains (Hughes et al., 2008), which are proposed to encode putative functional 
domains of the Otopetrin gene family, we hypothesized that expression of OTOP2 and 
OTOP3 would also modulate [Ca2+]i in a similar manner to OTOP1.  
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The localization of EGFP-tagged proteins shows interesting characteristics. 
EGFPOTOP2 was prominently localized to the plasma membrane (PM) (arrow) (Figure 
2A), while most EGFPOTOP3 was found in the endoplasmic reticulum (ER) (arrowhead) 
(Figure 2B), reminiscent of EGFPOTOP1. This suggested that OTOP2 may be trafficked 
differently from the other paralogues. 
 Wildtype COS7 cells show a biphasic response to 200 μM ATP, where a sharp 
initial peak is followed by a plateau phase, which lasts until removal of the agonist 
(wash) (Hughes et al., 2007). Otop1-expressing cells no longer show the initial peak but 
still have an increase in [Ca2+]i characterized by a similar plateau phase. Previous studies 
have shown that the initial peak and plateau phase depicts the release of intracellular Ca2+ 
and influx of extracellular Ca2+, respectively (Hughes et al., 2007). In terms of agonist 
sensitivity, EGFPOtop1 expressing cells responded to 200 μM ATP, ADP, and UDP 
(only half amount of the response compared to ATP and ADP) with increases in [Ca2+]i, 
but responded minimally to 200 μM ATPγS, 50 μM αβMeATP and 50 μM 2MeSATP 
(methyl-S-ATP).    
When EGFPOtop2 was expressed in COS7 cells a similar modulation of 
purineregic response was observed (Figure 2C). In EGFPOtop2-positive cells, the initial 
peak was absent, and the plateau phase persisted in response to 200 μM ATP. The agonist 
sensitivity of EGFPOtop2-expressing cells was similar to that of EGFPOtop1, except for 
the response to 2MeSATP. Stimulation with 2MeSATP showed a positive increase in 
[Ca2+]i, where the level of the plateau phase was lower than when stimulated with 200 
μM UDP. The response profile of EGFPOtop3 expressing cells to purinergic ligands was 
exactly the same as that of EGFPOtop1 (Figure 2D), suggesting a more functional 
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redundancy between OTOP1 and OTOP3, at least in terms of modulating Ca2+  
homeostasis in response to purinergic stimuli. 
 
Future directions 
 Otopetrin 2 (Otop2) and 3 (Otop3) are paralogous genes of mouse Otop1. They 
express highly conserved Otopetrin Domains (Hughes et al., 2008), and their expression 
patterns show extensive overlap (Hurle et al., 2003). Otop1 is thought to be expressed in 
many major organs, but the fact that the apparent phenotype in the Otop1 mutants (Hurle 
et al., 2003; Sollner et al., 2004) and the knockout is otoconial agenesis led us to 
hypothesize that there could be a considerable degree of redundancy between the three 
Otopetrins in mouse. Since Otop3 showed the most restricted expression pattern, we 
decided to generate a knockout allele of Otop2 (Otop2nβgal) and ultimately produce 
double knockout mice with the previously made Otop1 null allele (Otop1βgal).  
 No apparent phenotype in Otop2nβgal/nβgal mice and no new phenotype in 
Otop1βgal/βgal;Otop2nβgal/nβgal (other than otoconia agenesis) mice was observed, 
suggesting that OTOP2 and OTOP3 may have significant functional redundancy with 
OTOP1. To study this possibility we would need to generate a null allele of Otop3. 
Alternatively, OTOP2 may have a subtler physiological role that will need a more 
detailed analysis to elucidate. To explore this possibility, various expression and 
functional analyses with Otop2nβgal/nβgal and Otop1βgal/βgal; Otop2nβgal/nβgal mice would 
need to be followed.    
 Before pursuing detailed expression analysis, the integrity of nβGAL in Otop2 
null allele needs to be checked. So far, we have not found any tissue that can serve as a 
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positive control for Otop2 expression. Previously published microarray data (Hurle et al., 
2003) suggested several tissues with high expression of Otop2, such as brown fat, small 
intestine, salivary gland, tongue epidermis, stomach, kidney, etc. After checking Otop2 
mRNA levels in these organs, those that give a positive result will be tested for X-gal 
activity. One of the top priorities would be to check Otop2 expression in the inner ear, 
including cochlea.  
 Gross morphology of the inner ear is not affected by ablating Otop2, but the close 
proximity of Otop2 and Ush1g suggest that further exploration of possible inner ear 
phenotypes is warranted. Since Ush1g lies within an intron of Otop2, the promoter and 
regulatory domains for Ush1g expression could be embedded in Otop2 and these genes 
may be co-regulated. To ensure that Otop2 targeting does not interfere with the normal 
expression of either neighboring genes, the expression level of Ush1g needs to be 
checked and compared in the wildtype and Otop2nβgal/nβgal mice. Alterations in Ush1g 
expression might cause a Ush1G syndrome, with ocular and cochlear malformations. 
Taking this into account, hearing and eye function tests will also be pursued.  
 The observation that OTOP2 and OTOP3 can also modulate purinergic response 
in COS7 in a similar manner to OTOP1 suggests that Otopetrin family proteins could 
have a conserved role in regulating Ca2+ homeostasis. Notably, the possible expression of 
Otopetrins have been shown (Hurle et al., 2003) in organs that require critical regulation 
of Ca2+, such as kidney, intestine and skeletal tissues. Studying possible defects 
(functional and/or developmental) in these organs in Otop2nβgal/nβgal and Otop1βgal/βgal; 
Otop2nβgal/nβgal mice should reveal more in vivo functions of the Otopetrin family proteins.      
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Figure 1. Targeting scheme of Otop2nβgal allele. A) Otop2 has one splice variant, and its 
transcription starts at exon2. A β-galactosidase gene and LoxP-neo cassette was inserted 
in-frame with the second amino acid in exon 2 by homologous recombination using 4.8 
and 2.8 kb 5’ and 3’ homology arms, respectively. The 5’ and 3’ probes used for 
Southern Blotting were extrinsic to the targeting vector. B) Otop2 gene has Ush1g and 
Otop3 in close proximity. Ush1g lies within the first intron of Otop2 (1.5 kb 5’ to exon2), 
and is transcribed in the opposite direction as Otop2. Otop3 is located 3 kb downstream 
of exon7 of Otop2, and is translated in the same orientation as Otop2.  C) Southern 
Blotting result with wildtype (Otop2+/+), het (Otop2nβgal/+), hom (Otop2nβgal/nβgal) mouse 
tails. For 5’ and 3’ probes, the band sizes for the wildtype and null allele are 13 and 9 kb, 
16 and 12 kb, respectively. D) Multiplex genomic PCR result. The product sizes for the 
wildtype and null allele are 527 and 380 bp.  
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Figure 2. Response of GFPOtop2 and GFPOtop3-expressing COS7 cells to different 
purinergic agonists. A) COS7 cells expressing GFPOtop2. GFP signal is apparent in a 
punctate pattern at the plasma membrane (arrow). B) Cells expressing GFPOtop3 show 
GFP localization at the endoplasmic reticulum (arrowhead). C, D) GFPOtop2 (WT (n=7), 
GFPOtop2 (n=11)) and GFPOtop3-expressing cells (upper graph;WT( n=3), GFPOtop3 
(n=4), lower graph; WT(n=1), GFPOtop3 (n=15)) show different agonist sensitivity to 
modulating purinergic response. GFPOtop2 and GFPOtop3-positive cells respond to 
ATP=ADP>UDP>Methyl-S-ATP and ATP=ADP>UDP, respectively,  
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Introduction 
 
In the vestibular system, the otolith organs contain mechanical inertial transducers, 
called otoconia, which are essential for detecting linear acceleration of the head with 
respect to gravity. In birds, the utricle, saccule, and lagena contain these tiny biominerals, 
embedded in a gelatinous membrane overlying the sensory epithelium. The fact that 
otoconia are approximately 3 times denser than the surrounding endolymph fluid 
(Carlstrom et al., 1953; Grant and Best, 1987) allows them to be effectively displaced and 
move the underlying stereocila of the sensory cells, leading to initiation of a neuronal 
response. In the absence of otoconia, severe balance problems occur (Jones et al., 1999; 
Ornitz et al., 1998). 
Each otoconium consists of a glycoprotein/proteoglycan core surrounded by the 
calcite polymorph of calcium carbonate. The core comprises Otoconin 90 (OC90), which 
accounts for 90% of the total protein in otoconia, and several minor proteins (Thalmann 
et al., 2006) have been recently discovered. OC90 is homologous to secretory 
phospholipase A2 (sPLA2), and has been cloned from mouse and chicken (Wang et al., 
1998; Wang et al., 1999). Production of Oc90 is prominent in the nonsensory cell types 
of the semicircular canal, utricle, saccule and the cochlear duct (Verpy et al., 1999). 
Immunostaining of the OC90 protein in the nonsensory patches fades by post-natal day 0, 
whereas OC90 signal in the otoconia persists even after birth in mice. 
Calcification of the proteinaceous otoconial precursor is rapid and ultimately 
results in mature otoconial shape, characterized by barrel shaped morphology with 
trihedral faceted ends (Ballarino and Howland, 1982; Ballarino et al., 1985; Lim, 1973; 
Ross and Peacor, 1975) (Figure 1A). In the quail (Coturnix japonica), the growth of 
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otoconia begins at E5 in the saccule and E6 in the utricle and fully developed by E12 in 
the saccule and and post-hatch day 7 (P7) in the utricle (Figure 1B, C). Otopetrin 1 
(OTOP1) is essential for the nucleation and growth (calcification) of otoconia (Hughes et 
al., 2004). All the mutants of Otop1 (tilted (tlt), mergulhador (mlh), and backstroke (bsk)) 
show nonsyndromic otoconial agenesis with no abnormal phenotypes in inner ear 
morphogenesis (Hurle et al., 2003; Ornitz et al., 1998; Sollner et al., 2004). Studies with 
these mutants suggested that OTOP1 has an essential and conserved role in the timing of 
formation and the size and shape of the developing otoconia/otolith (Hughes et al., 2004). 
Consistent with its proposed role, Otop1 mRNA is expressed in the sensory epithelium 
(Hurle et al., 2003). Recently, three separate highly conserved regions of the murine 
Otop1 cDNA have been identified in expressed sequence tag (EST) clones of chicks, 
strongly suggesting that similar mRNA and protein are also expressed in quails. As a 
multi-transmembrane protein, OTOP1 is postulated to be located in the calcium-enriched 
microvesicles called globular substance during initial stage of otoconial formation (Hurle 
et al., 2003). Coalesced OC90 would interact with these microvesicles and this 
interaction would initiate crystal nucleation and growth (Thalmann et al., 2001). 
During manned spaceflight, 80-90% of the flight crews experienced space motion 
sickness, such as disorientation, nausea, and emetic attacks during the first 48-72 hours of 
weightlessness (Davis et al., 1988; Reschke et al., 1998; Thornton et al., 1987). It was 
apparent that the lack of gravity as a constant stimulus during spaceflight produced 
profound changes in vestibular system function, but the basic mechanisms that are 
affected by changes in gravity are poorly understood. The potential for gravity to 
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modulate vestibular mechanotransduction lead to the hypothesis that gravity could serve 
as a regulatory factor in the development of the otolith organs. 
 One possibility is that the otoconia structure and/or the afferent innervations are 
affected by altered gravity conditions. Several previous studies have shown that this may 
be true as changes in size of otoconia (Fermin et al., 1996; Ross and Donovan, 1986a; 
Wiederhold et al., 2000), in the receptor-afferent morphology (Gaboyard et al., 2002; 
Raymond et al., 2000; Ross, 1993), in vestibular afferent responsiveness (Boyle et al., 
2001; Bracchi et al., 1975; Correia et al., 1992; Jones et al., 1993), and in vestibular 
related neuromotor responses (Dai et al., 1994; Sebastian et al., 1996; Takabayashi et al., 
1993; von Baumgarten et al., 1975) were observed in animals exposed for brief periods in 
either microgravity or hypergravity.  
Interestingly, exposure of mature animals to altered gravity environment (at least 
short term) appear to produce little detectable changes in otoconia at either the 
morphological or calcification level (Krasnov, 1991; Ross et al., 1985; Ross and 
Donovan, 1986b; Sondag et al., 1995). However, definite and systematic changes are 
observable when animals are exposed to altered gravitational states during embryonic 
development (Hara et al., 1995; Moorman et al., 1999; Pedrozo et al., 1997; Sondag et al., 
1996; Wiederhold et al., 2000). To fully understand the effect of altered gravity on 
otoconia formation, it is necessary to analyze the molecular processes underlying 
biosynthesis of otoconia in embryos from various developmental time points after a 
chronic exposure to conditions of altered gravity throughout development.  
In this study, we used Japanese quails developed under normal (1G) and 
hypergravity (2G) (Figure 2) to quantitatively determine how gravity affects the 
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expression of Oc90 and Otop1. As OC90 and OTOP1 are indispensable for the two main 
mechanisms forming mature otoconia, protein core formation and the calcification 
process, respectively, we investigated effects of gravity on the expression of the genes 
involved in otoconia biosynthesis. In parallel, calcium weight of otoconia in these 
samples was measured to correlate with the results of the expression study. Quail is an 
ideal model to study the effect of altered gravity because of its small size, short 
development period, and their non-altricial nature.  
 
Materials and Methods 
Gravity experiment  
Cooled fertilized eggs were exposed to normal (1G) or hypergravity (2G) for 
further development. The 1G eggs were kept in a standard lab incubator maintained at 
37.5°C with a relative humidity of 55%. The hypergravity condition of 2G was provided 
by constant velocity rotation (365°/sec) using a 0.396m radius custom designed 
laboratory centrifuge housed inside an incubator (SHOT Inc.) (Figure 2).  
 
Tissue dissection 
In E2 through E7 embryos the region of the temporal bone containing the 
vestibular end organs and basilar papilla was dissected free and used for inner ear tissue.  
In E8 through E14 embryos the entire vestibular labyrinth, including the basilar papilla 
and lagena, was dissected free from the temporal bone and designated inner ear tissue.  
All tissues for qPCR were stored in RNA Later (Ambion) at -20C until use. Tissues from 
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3 embryos were collected in a single tube, and 3 tubes were prepared for each 
developmental time point (E2, 4, 6, 8, 10, 12, and 14).  
 
Measurement of otoconial calcium weight 
Temporal bones of E12 and E14 embryos were removed from the half head under 
sodium cacodylate buffer and fixed overnight. The endorgans (utricles and saccules) with 
the otoconia attached were then dissected free from the temporal bone, dried, and 
weighed. The calcium in the otoconia was then removed by EDTA. The remaining tissue 
was then dried and reweighed. Subtracting the second weighing from the first yielded the 
total weight of calcium removed from the otoconia. 
 
Extraction of total RNA and cDNA synthesis 
  Total RNA was purified using RNeasy (Qiagen) spin columns. RNA was treated 
with RNase-free DNase (Qiagen) to avoid genomic DNA contamination. Total RNA was 
eluted in 40μl. 200ng of RNA was used for each reverse transcriptase reaction. 
SuperScript first strand synthesis system (Invitrogen) was used to generate cDNA, and 
samples without reverse transcriptase were processed in parallel to serve as negative 
controls. Prior to real-time quantitative RT-PCR, semi-quantitative RT-PCR with quail 
GAPDH primers was performed to check the efficiency of cDNA synthesis.  
 
Real-time quantitative RT-PCR 
The measurement was carried out in a 96-well plate in an iCycler machine.  23μl 
of mastermix (iQTM SYBR green supermix, forward and reverse primers and RNase-free 
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water) and 2μl of cDNA were added to each well. Each sample was loaded in triplicates. 
After PCR reaction, products were subjected to gel electrophoresis to confirm 
amplification of correct target. Relative expression was calculated by the following 
formula; 2(- (ΔCt - ΔCt (baseline)), where ΔCt = Ct(Gene) – Ct(GAPDH) and ΔCt 
(baseline) = ΔCt of E9 inner ear 1G tissue. 
Gene                                  Primer sequence                                                              Product size    
                                                                                                                                     (base pair) 
GAPDH                            5’- GATGGGTGTCAACCATGAGAAA -3’                       450 bp 
                                          5’- ATCAAAGGTGGAAGAATGGCTG -3’ 
Otopetrin 1                        5’- TTAATTCTGGACTCCTTTAAAATTGGA -3’           192 bp 
                                          5’- GAACACAGAATGGATAACCCCAAAC -3’ 
Otoconin 90                      5’- ACCTCTCCAGGCTCCTTCCA -3’                               201 bp 
                                          5’- TCCTGCAGGTCCATTGGGTC -3’ 
Otogelin                            5’- GAGGAATGTAATAATTGCACTTGCA -3’                332 bp 
                                          5’- GGCAGGTTAATTTTGTACTGGTCATATA -3’   
 
Oc90 in-situ hybridization  
700bp digoxigenin labeled probes were produced by PCR using primers specific 
to chicken Oc90.  10 μm frozen sections were incubated with sense and anti-sense probes 
overnight at 55oC. Alkaline phosphatase conjugated anti-DIG antibody was used along 
with NBT/BCIP to localize the expression pattern of mRNA. Nuclear fast red was used 
as a counterstain.   
 
OC90 immunohistochemistry 
A rabbit anti-chicken OC90 antibody, which recognizes part of the linker region 
between the two PLA domains, was incubated at a 1:1000 dilution on 10 μm frozen 
sections overnight at 4oC.  A Cy-3 conjugated horse anti-rabbit secondary antibody was 
used to localize the expression pattern of protein under epi fluorescence.  Nuclei were 
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stained with bisbenzimide. Control sections were incubated with pre-immune serum or 
secondary antibody only.  
 
 
Results 
 
Expression pattern of Otoconin 90 (Oc90) mRNA and protein.  
To determine whether the expression pattern of Oc90 is conserved in quails, in-
situ hybridization and immunohistochemical analysis was performed on developing quail 
tissues (Figure 3). Oc90 mRNA expression was first detected at E6 in the restricted 
regions of the cochlear duct and otic vesicle. From E10, the localization of Oc90 mRNA 
expression was apparent in the non-sensory epithelium of the vestibular labyrinth and in 
the tegmentum vasculosum (cochlea). A high level of Oc90 expression continued through 
E12, and after this point Oc90 mRNA subsequently declined and was not detected at E15. 
Sections incubated with the antisense probe did not show any positive Oc90 signal (data 
not shown). 
The onset of OC90 protein expression lagged behind that of its mRNA. OC90 was 
first faintly detected at E8, and stronger labeling was observed from E10 through P7. The 
apical regions of the non-sensory epithelium of the vestibular labyrinth showed the 
strongest signal. The presence of OC90 in otoconia was prominent starting at E12. 
Sections incubated with pre-immune serum or secondary antibody only, showed no 
labeling (data not shown). This pattern of expression was consistent with what had been 
previously observed in other species (Verpy et al., 1999).  
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Hypergravity does not significantly affect Oc90 expression. 
 To investigate the effect of gravity on the biosynthesis of otoconia during 
development we developed a system which can induce hypergravity (2G) through 
sustained centrifugation (Figure 2, materials & methods). Quail eggs were tightly held 
within each cylindrical slot and were maintained in the system throughout development 
until analysis. No change in body weight between embryos grown at 1G and 2G 
conditions (Figure 4) suggested that embryonic development was not delayed or 
significantly affected by hypergravity centrifugation. This supported the idea that any 
change in expression level of Otop1 and Oc90 was not a consequence of altered growth 
rates of the animals.  
 An important control experiment was to confirm the specificity of our tissues that 
were used for quantitative RT-PCR (qRT-PCR) analysis, as brain and inner ear temporal 
bones were too close to each other and therefore prone to contamination during the 
dissection process. Otogelin which is a component of the glycoproteins specific to the 
acellular memebranes of the inner ear is not expressed in the brain, and therefore was a 
good positive control for inner ear tissue. cDNA from inner ear tissues was enriched with 
Otogelin message whereas brain tissue contained very little (Figure 5), confirming 
specificity of our tissue dissection. 
 qRT-PCR data showed that at 1G expression of Oc90 was minimal until E6, 
reached a maximum at E9 and decreased toward hatching (Figure 6). This expression 
pattern was consistent with what was observed by Oc90 in-situ hybridization (Figure 3), 
confirming the integrity of our qRT-PCR analysis. Importantly, the expression of Oc90 
throughout development was not affected by hypergravity. This result suggested that 
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chronic hypergravity condition is unlikely to affect otoconia protein core formation or 
that some compensation has occurred in early development such that the effect of 
hypergravity could not be revealed at the later time points. 
 
 
Hypergravity does not affect Otop1 expression or otoconia calcium weight. 
 To determine whether hypergravity can affect otoconia calcification, the 
expression level of Otop1 was assayed. At 1G, Otop1 showed a similar expression profile 
to that of Oc90 (Figure 7). The rate of increase in expression level during early 
development increased greatly at E6 when immature, double fluted otoconial begin to 
form on the utricle (Figure 1C). Maximal levels of Otop1 mRNA were observed at E9, 
and after E9, the level dropped dramatically. The low level of Otop1 was maintained until 
hatching. Possible effects of hypergravity on Otop1 expression was observed at E9 and 
E10, but the difference did not achieve statistical significance. This result suggested that 
the hypergravity condition did not interfere with calcification of otoconia. Accordingly, 
otoconial calcium weight did not show any significant difference between animals grown 
at normal and hypergravity (Figure 8). These results showed that the effect of gravity as 
an epigenetic determinant of formation of otoconia is relatively weak. 
 
Conclusion 
 Gravity is sensed by receptors in the otolithic organs of the vestibular system. 
Otoconia, the dense biominerals that lie within the otolithic organs, are essential inertial 
transducers which move with respect to gravity and initiate a neuronal response (Hughes 
et al., 2006). Many previous studies reported changes in otoconia morphology and size in 
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animal models exposed to different gravity conditions (Hara et al., 1995; Moorman et al., 
1999; Pedrozo et al., 1997; Sondag et al., 1996; Wiederhold et al., 2000), suggesting 
gravity as an epigenetic factor for regulating biosynthesis and maintenance of otoconia.   
 In this study, we investigated the effect of chronic hypergravity treatment on 
development of quail eggs by examining the expression of two important genes 
previously implicated for otoconia formation, Otoconin90 (Oc90) and Otopetrin 1 
(Otop1). Interestingly, the onset and decrease in expression of the two genes at normal 
gravity were tightly correlated, with maximum expression at E9, when mature otoconia 
are already localized over the sensory epithelia (Figure 1C). Higher levels of Oc90 and 
Otop1, observed after initiation of otoconial calcification, suggest that relatively little 
amount of OC90 and OTOP1 are required to initiate otoconia formation. Alternatively, 
accumulated OC90 and OTOP1 may serve an additional role during growth and possibly 
maintenance of otoconia.   
 When the expression of Oc90 and Otop1 and calcium weight of the otoconia were 
compared in animals grown at normal (1G) and hypergravity (2G) no prominent 
difference was observed. This suggests that the effect of change in the force of gravity is 
unlikely to affect otoconia development through regulation of these genes. These data 
highlight the necessity to study the morphology and function of efferent and afferent 
innervations that innervate the sensory cells beneath the otoconia mechanotransduction 
structure.  Importantly, our preliminary data show that calyx afferent formation is delayed 
in microgravity, with smaller axon diameters and smaller termination fields for all 
afferent types as compared to 1G controls. Animals raised to E12 in 2G appear to have 
the opposite result, with larger axonal diameters and increased terminal fields. 
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Comparison of expression of genes critical for formation of afferent structures in the 
otolithic organs, such as brain-derived neurotrophic factor (BDNF), may provide us 
additional clues to the effect of gravity on vestibular system development and function.   
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Figure 1. Development of otoconia in the embryonic quail. A) SEM pictures showing 
immature (double fluted) and mature (mature faceted) otoconia. Scale bar indicates 2.5 
μm. B) Comparison of otoconia growth in the saccule and utricle during development and 
after hatching. Arrow indicates the hatching point. The utricular sensory epithelium (SE) 
acquires otoconia faster than the saccular SE after E10, and this faster increase in the 
utricle consequently results in larger otolith area compared to the saccule. After hatching, 
otoconia growth no longer occurs and mature otoconia are maintained in the adult. C) 
Characteristics of otoconia development before hatching. Time points in parenthesis 
indicates parallel developmental ages in the mouse. Figures A, B adapted from (Dickman 
et al., 2004). 
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Figure 2. The equipment used to induce hypergravity during quail eggs 
development. A) Outside view of the equipment. B) Each quail egg was placed within a 
cylindrical chamber connected to the main rotor. Rotating these chambers created a 
centrifugation effect. C) A quail egg is securely restrained within the cylindrical chamber. 
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Figure 3. Oc90 in-situ hybridization and OC90 immunohistochemistry. Oc90 mRNA 
expression was first detected at E6 in the nonsensory epithelia of the vestibular and 
cochlear labyrinth. Positive signals were detected until E12, and by E15, Oc90 mRNA 
was no longer detectable. OC90 protein was first faintly detected at E8, and a stronger 
signal was observed in the apical regions of the nonsensory epithelia of the vestibular 
labyrinth from E10 through P7. Starting at E12, OC90 was detected within the otoconia. 
Sections incubated with antisense probe, pre-immune serum or secondary antibody only, 
showed no signal. M: medial, V: ventral, D: dorsal, L: lateral. 
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Figure 4. Comparison of body weight of embryos developed at normal (1G) and 
hypergravity (2G). Body weight of embryos grown at 1G and 2G showed no significant 
difference. Data points represent mean values with standard deviation. 
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Figure 5. Relative quantification of Otogelin expression using qRT-PCR. Expression 
of Otogelin was first detected at E6. Inner ear tissues expressed much higher level of 
Otogelin compared to the brain, confirming the specificity of the tissues used for qRT-
PCR analysis. Data points represent mean values with standard deviation.  
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Figure 6. Relative quantification of Oc90 gene expression at 1G vs 2G. Production of 
Oc90 reached a maximum at E9 and decreased toward hatching. Hypergravity had no 
significant effect on Oc90 expression. Data points represent mean values with standard 
deviation.  
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Figure 7. Relative quantification of Otop1 expression at 1G vs 2G. The level of Otop1 
mRNA slowly increased during development, and showed regression after E9 toward 
hatching. Hypergravity conditions did not result in a significant change in Otop1 
expression levels. Data points represent mean values with standard deviation. 
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Figure 8. Comparison of otoconial calcium weight in 1G and 2G animal. At E12 and 
E14, otoconial calcium weight was measured by subtracting the weight of fused otoconia 
after EGTA treatment from the original weight. Otoconial calcium weight did not show 
any significant difference between animals grown at normal and hypergravity. Data 
points represent mean values with standard error. SAC: saccule, UT: utricle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 135
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 136
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion and Future Directions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 137
Conclusion 
 
Otopetrins define a new gene family with highly conserved domains (Otopetrin 
Domains) (Hughes et al., 2008; Hurle et al., 2003). Otopetrin 1 (Otop1) was discovered 
by positional cloning of the tilted mice, which carry a missense mutation within the gene 
(Hurle et al., 2003). The mouse and zebrafish mutants of Otop1 show a non-syndromic 
otoconial agenesis phenotype, indicating that the function of OTOP1 is essential for 
otoconia formation (Hughes et al., 2004; Hurle et al., 2003; Ornitz et al., 1998; Sollner et 
al., 2004).  
Consistent with its proposed function, Otop1 is expressed in the sensory 
epithelium of the utricle and saccule beneath the otoconia membrane (Hurle et al., 2003). 
As a multi-transmembrane protein, OTOP1 was predicted to be localized to the plasma 
membrane or vesicular structures. Previous results that the isolated globular substance 
vesicles, the otoconia precursors, can have local [Ca2+] increase in response to ATP 
(Suzuki et al., 1997) suggested a possible involvement of purinergic signaling during 
otoconia formation. This observation led us to hypothesize that OTOP1 may localize 
within globular substance vesicles and may induce calcification of otoconia in response 
to purinergic stimuli.  
In vitro studies with Otop1-expressing COS7 cells showed that OTOP1 has the 
ability to modulate [Ca2+]i by inhibiting P2Y receptor activity and allowing extracellular 
Ca2+ influx (Hughes et al., 2007). Because this activity was tested in heterologous cells 
we needed a system to more closely model the in vivo environment to test biochemical 
activity of OTOP1 during otoconia formation.  
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Possible expression of OTOP1 in organs other than the inner ear (Hurle et al., 
2003) suggested that OTOP1 could have additional functions but that they have not been 
revealed in any of the mouse mutants. To decipher the additional in vivo functions of 
OTOP1, a null allele of Otop1 (Otop1βgal) was generated and analyzed. Homozygous 
Otop1βgal/βgal mice were viable and the primary phenotype was non-syndromic otoconia 
agenesis. The presence of the β-galactosidase gene allowed us to efficiently mark its 
expression. Otop1 was found in the non-striolar region of the utricle and saccule 
throughout development and this expression pattern persisted in the adult. OTOP1 protein 
localized to the apical side of the supporting cells. Analysis of the purinergic response in 
primary macular epithelial cultures showed that in vivo OTOP1 inhibits P2Y receptor-
mediated release of intracellular Ca2+ stores and activates a P2X receptor-like influx of 
extracellular Ca2+. We also found that the P2Y inhibitory activity of OTOP1 was 
dependent on the presence of extracellular Ca2+, suggesting a role for OTOP1 in sensing 
extracellular or intravesicular Ca2+ concentrations. These data suggested that the 
identified in vivo biochemical activity of OTOP1 may be important for otoconia 
formation and maintenance.   
Because the same phenotype was exhibited in Otop1βgal/βgal, Otop1tlt/tlt, and 
Otop1mlh/mlh mice it was likely that both tlt and mlh mutations resulted in inactivation of a 
common biochemical activity of OTOP1. Since tlt and mlh mutations lie within distinct 
Otopetrin Domains (Hughes et al., 2008) we hypothesized that the mechanism by which 
OTOP1 function is altered or disrupted by these mutations could be different. Importantly, 
both endogenous mutant proteins showed altered subcellular localization compared to the 
wildtype OTOP1. As a multi-transmembrane protein OTOP1 signals were in a punctate 
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pattern and were localized near the apical end of the sensory epithelium, whereas most 
mutant signals stayed between the mid and basal end. Interestingly, the mlh mutation 
seemed to affect more of the biochemical function of OTOP1 than tlt, and further 
ratiometric imaging with primary utricular macular cultures will be pursued to confirm 
this effect in vivo. These data not only showed the effect of each mutation but also 
suggested putative functions of the Otopetrin Domains (OD-I and II) bearing each 
mutation. 
The overlapping pattern of expression (Hurle et al., 2003) and the otoconial 
agenesis phenotype in Otop1βgal/βgal mice suggested that OTOP2 and OTOP3, the 
paralogues of OTOP1, could have possible functional redundancy. In vitro experiments 
showed that OTOP2 and OTOP3 can mimic the biochemical function of OTOP1. 
However, when we generated the knockout for Otop2 and double knockout for Otop1 and 
Otop2, no additional phenotype besides otoconial agenesis was observed even though 
successful targeting of each gene was clearly confirmed. This result leads us to pursue a 
more careful analysis of the Otop2 null allele and to pursue generating a null allele for 
Otop3.  
Otoconia detects movement with respect to gravity and also can be disturbed by a 
change in the force of gravity. As the change in otoconia was observed when embryos 
were grown under altered gravity, we examined whether expression of Otoconin90 
(Oc90) and Otop1, which are essential for otoconia biosynthesis, could be affected in 
animals exposed to chronic hypergravity condition. Both genes showed an increase in 
expression during quail development, peaking at E9, and regressing afterwards until 
hatching. Hypergravity treatment did not seem to affect this expression pattern for either 
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gene, although a slight effect of hypergravity on Otop1 expression observed with E9 and 
E10 tissues deserves further confirmation.   
 
Future Directions 
Otopetrin family knockout mice 
 To fully understand the biochemical activities of Otopetrin family proteins in 
otoconial formation and to identify their role in the development and function of other 
organ system, generation of a knockout allele for each Otopetrin gene and double or 
triple knockout alleles for different combinations of Otopetrin family genes will be 
necessary.  
 Homozygous knockout of Otop1 (Otop1βgal/βgal) is viable and shows otoconia 
agenesis. This phenotype confirmed that the otoconial agenesis found in Otop1 mutants is 
due to loss of OTOP1 activity and not due to an alteration of native OTOP1 function. At 
this point, it is likely that the most important developmental role of OTOP1 is formation 
of otoconia. In addition to the utricle and saccule in the inner ear, positive βGAL staining 
was also observed in lactating mammary gland, kidney, and a faint staining in the brain. 
However, no apparent phenotype was observed in these organs. It is possible that OTOP1 
may be expressed in these organs, but without any function, or there may be redundancy 
with other proteins that mask the function of OTOP1.   
 Redundancy between Otopetrin family proteins are suggested from their 
overlapping patterns of expression (Hurle et al., 2003). Importantly, ratiometric Ca2+ 
studies with COS7 cells expressing OTOP2 and OTOP3 showed that these proteins could 
also modulate [Ca2+]i in a similar manner to OTOP1, with OTOP3 having an identical 
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purinergic against sensitivity to that of OTOP1. This conserved biochemical function 
further supports the likelihood that there is redundancy between Otopetrins, at least in 
terms of modulating [Ca2+]i. Therefore, if multiple Otopetrins are present in the same 
tissue, loss of activity of one Otopetrin could be compensated by other Otopetrins. This 
may explain why a single knockout allele of an Otopetrin may not fully reveal its in vivo 
function. Thus, future studies must emphasizes the necessity of generating double and 
possibly triple knockouts of Otopetrin family genes.   
 Homozygous Otop2 knockout mice (Otop2nβgal/nβgal) are viable and so far a 
phenotype has not been identified. We think that the function of OTOP2 may be subtler 
than expected and/or the function of OTOP2 may be masked by redundancy with OTOP1 
or 3. Identifying the tissues that express Otop2 with nβGAL should help to focus 
experiments designed to identify phenotypes.   
Considering that a novel phenotype has not been identified in homozygous 
Otop1βgal/βgal; Otop2nβgal/nβgal double knockout, and that there are more functional 
similarities between OTOP1 and OTOP3 in modulating Ca2+, generation of an Otop3 null 
allele and generation of double knockouts with the Otop1 and 3 or Otop2 and 3 seems 
indispensable to uncovering the redundancy between Otopetrin proteins. We found out 
that EUCOMM had already generated Otop3 targeted ES cell line. OTOP3 was recently 
discovered as novel gene expressed in retina cone cells (Corbo and Cepko, 2005). 
Therefore, morphology of the retina and eye function will need be pursued when the null 
allele is generated.  
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Functional domains of Otopetrin proteins 
Topological models generated through sequence comparison of multiple species 
identified three highly conserved domains within the Otopetrin family (Hughes et al., 
2008). We have designated these domains as Otopetrin domains (OD-I, II, and III). The 
considerable conservation between vertebrate and invertebrate Otopetrin sequences 
suggests conservation of structure and function. To better understand the role of these 
sequences in the function of OTOP1, EGFP-tagged C-terminal deletion series and EGFP 
chimeric constructs containing isolated Otopetrin domains will need to be made and 
examined for the ability to modulate intracellular [Ca2+]. Previous studies showed two 
major components of OTOP1 activity in COS7 cells (Hughes et al., 2007): 1) Otop1 
expressing cells showed decreased release of intracellular Ca2+ stores in response to ATP, 
but could release stored Ca2+ in response to stimuli at other G-protein coupled receptors, 
suggesting that OTOP1 specifically inhibited the activation of P2Y in response to ATP; 
2) Otop1 expressing cells exhibited a novel ATP-gated influx of extracellular Ca2+, which 
had unique nucleotide sensitivity not observed in other P2X channels. We hypothesize 
that the two most highly conserved Otopetrin domains may be required for different 
components of these activities (binding purinergic agonists, suppressing P2Y activity, 
inducing influx of extracellular Ca2+).   
 The set of biochemical functions of OTOP1 suggest that Otop1 could constitute 
an ion channel on its own or alter the activity of an ion channel, transporter, or exchanger. 
Using P2X specific protocols, the correct conditions for measuring current induced 
calcium influx have not been identified. This suggests the need for continued attempts at 
electrophysiology of Otop1 expressing cells using a variety of conditions. Alternatively, 
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lack of current in Otop1 expressing cells could indicate that OTOP1 acts as, or with, a 
transporter or exchanger, which do not always generate significant alterations in 
membrane current.  
Examination of the primary amino acid sequence of the Otop family does not 
suggest the presence of an ATP-binding site, or any regions that could be consistent with 
hydrolysis of nucleotides. Since Otop constitutes its own, highly conserved family it may 
contain novel or cryptic nucleotide binding and hydrolysis domains, or may interact with 
other known or novel proteins to accomplish these activities.  
 
Other biochemical roles of Otop1  
 So far, search for biochemical functions of OTOP1 has been primarily related to 
the modulation of intravesicular Ca2+ observed in globular substance vesicles (Suzuki et 
al., 1997). Studies from our lab have shown in vitro and in vivo evidences (Hughes et al., 
2007) which suggested that OTOP1 may actually be the protein responsible for locally 
increasing Ca2+ and consequently allowing calcification of otoconia particles. We 
hypothesized that OTOP1 modulates the activity of P2Y receptor-mediated regulation of 
[Ca2+]i.  
Recently, purinergic signaling has been linked to the regulation of membrane 
trafficking in addition to regulation of Ca2+ signaling in brown adipose tissue (BAT) (Lee 
et al., 2005). They concluded that multiple P2 receptors mediate the ATP responses of 
BAT cells, and that membrane trafficking is regulated by a P2 receptor showing 
“unusual” properties. Since OTOP1 has unique agonist specificity to purinergic stimuli, 
and data from microarray study (ref) and our qRT-PCR data (data not shown) show 
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expression of Otop1 in BAT, it is possible that OTOP1 may be involved in regulating 
membrane trafficking in BAT in response to purinergic stimuli. 
Membrane trafficking can be studied with FM1-43 dye labeling (Betz et al., 1996). 
FM1-43 can partition into the outer leaflet of the plasma membrane but does not cross 
between membrane leaflets. Fluorescence increases many fold after partitioning into 
membrane, thus by examining the rate of change in fluorescence, the rate of membrane 
addition or loss can be deduced. Future studies will use Otop1+/+, Otop1βgal/βgal, Otop1tlt/tlt, 
and Otop1mlh/mlh utricular macular culture cells and brown adipocyte cells and compare 
the rate of change in FM1-43 fluorescence in response to different purinergic stimuli. 
This experiment will reveal a possible function of OTOP1 in membrane trafficking in the 
maculae and in BAT. Because BAT is important for thermo-regulation Otop1βgal/βgal mice 
will also be tested for cold stress tolerance.   
 
OTOP1 topology 
 Analysis of the primary structure of OTOP1 suggests a 12 span transmembrane 
domain structure with cytosolic localization of the N- and C-termini (Hughes et al., 2008). 
It will be important to experimentally examine this model, especially if OTOP1 is 
predicted to behave as a novel channel. Knowledge of the domains of OTOP1 that are 
intracellular will be essential information to have before we can begin studies to identify 
other proteins that interact with cytoplasmic domains of OTOP1.  
 To examine the topology of OTOP1, the method used by Lorenz et. al., called 
fluorescence protease protection (FPP) (Lorenz et al., 2006) can be applied. FPP makes 
use of EGFP tagged proteins transfected in heterologous cells and imaging the integrity 
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of the EGFP before and after adding trypsin with and without selective cell 
permeabilization process. Similar biochemical function of OTOP1 with different epitope 
tags (Hughes 2007) suggests that the transmembrane topology of the tagged molecules 
would be similar to that of the wildtype OTOP1. For this analysis, a C-terminal deletion 
series for Otop1-EGFP, in which proposed TM domains are sequentially deleted will be 
generated. Deletion of an odd number of TM domains should alter the cytoplasmic or 
extracellular localization of the C-terminal EGFP tag. COS7 cells will be transfected with 
these series of deletion constructs and examined for the localization of EGFP. Cells 
transfected to express Otop1-EGFP chimeric proteins and a red fluorescent protein (RFP) 
tagged control will be exposed to trypsin either before or after plasma membrane 
permeabilization by digitonin. Digitonin (1-50 μM) intercalates into cholesterol-rich 
membranes and causes the plasma membrane to become perforated. Cytosolic contents 
can then diffuse out of the cells, and small molecules, like trypsin, can diffuse into the 
cells.  Notably, the permeabilizing effect of digitonin affects the cholesterol-rich plasma 
membrane but not intracellular organelles that have much lower concentrations of 
cholesterol and are unaffected. If the fluorescent protein moiety on the expressed protein 
faces the environment exposed to trypsin (the cytoplasm), then its fluorescence signal 
should be lost. Conversely, if the fluorescent protein moiety on the expressed protein 
faces the environment protected from trypsin (the lumen of a compartment such as the 
ER), then its fluorescence should persist.  
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Identifying OTOP1 interacting proteins 
 The lack of obvious calcium binding or pore domains, or ATP binding or 
hydrolysis domains in the OTOP1 primary sequence suggests that OTOP1 may be part of 
a signaling complex.  So far, the best candidates for OTOP1 interacting proteins are P2Y 
receptors, NADPH Oxidase 3 (NOX3), and NOXA1.  
 Previous study has shown that overexpression of OTOP1 in COS7 cells does not 
interfere with G-protein coupled signaling downstream of P2Y receptor, suggesting more 
direct interaction of OTOP1 with the receptor itself. FLAG-Otop1 constructs are already 
made and can be used for immunoprecipitation in COS7 cells after transient transfection 
or in mouse utricles. Our anti-OTOP1 anitibody has been confirmed to work in Western 
Blots and the availability of all P2Y receptor antibodies allows us to apply the proposed 
technique. Ratiometric Ca2+ studies with mouse utricular cultures showed that OTOP1 
may most likely inhibit P2Y2 and/or P2Y4. This led us to collaborate with the laboratory 
of B. Robaye where the individual and double knockouts for P2Y2 and P2Y4 are 
generated. We will first look for any balance problems in these mice and examine 
whether intact otoconia are present in these mice.  
 The rationale for choosing NOX3 and NOXA1, which are required for generating 
reactive oxygen species (ROS) in the inner ear, as candidates for OTOP1 interacting 
protein, comes from the observation that mutants with loss of function mutations in these 
genes, headtilt and headslant, respectively, show similar phenotypes to tlt  and mlh 
mutants. All five mutant mice display non-syndromic otoconial agenesis, with normal 
formation and maintenance of the sensory maculae and non-sensory structures, which 
may suggest that OTOP1 and NADPH family proteins interact in a single pathway. 
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Previous study showed that NOX3 is an inner ear specific NADPH Oxidase and that 
NOXA1 is required for the generation of ROS by NOX3 (Banfi et al., 2004). Co-
transfection of OTOP1, NOX3, NOXA1, and NOXO1 (a second adaptor protein of the 
NOX3 complex) into COS7 cells and examination of both Ca2+ mobilization in response 
to ATP and ROS generation may help to elucidate interacting partners for OTOP1. In 
preparation for such experiments, we have obtained mammalian expression constructs for 
NOX3, NOXA1, and NOXO1 from the laboratory of B. Banfi (Banfi et al., 2004).  
 
References 
 
Banfi, B., Malgrange, B., Knisz, J., Steger, K., Dubois-Dauphin, M., and Krause, K. H. 
(2004). NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 
279, 46065-46072. 
 
Betz, W. J., Mao, F., and Smith, C. B. (1996). Imaging exocytosis and endocytosis. Curr 
Opin Neurobiol 6, 365-371. 
 
Corbo, J. C., and Cepko, C. L. (2005). A hybrid photoreceptor expressing both rod and 
cone genes in a mouse model of enhanced S-cone syndrome. PLoS Genet 1, e11. 
 
Hughes, I., Binkley, J., Hurle, B., Green, E. D., NISC Comparative Sequencing Program, 
Sidow, A., and Ornitz, D. M. (2008). Identification of the Otopetrin Domain, a conserved 
domain in vertebrate otopetrins and invertebrate otopetrin-like family members. BMC 
Evolutionary Biology 8:41. 
 
Hughes, I., Blasiole, B., Huss, D., Warchol, M. E., Rath, N. P., Hurle, B., Ignatova, E., 
Dickman, J. D., Thalmann, R., Levenson, R., and Ornitz, D. M. (2004). Otopetrin 1 is 
required for otolith formation in the zebrafish Danio rerio. Dev Biol 276, 391-402. 
 
Hughes, I., Saito, M., Schlesinger, P. H., and Ornitz, D. M. (2007). Otopetrin1 activation 
by purinergic nucleotides regulates intracellular calcium. Proc Natl Acad Sci U S A 104, 
12023-12028. 
 
Hurle, B., Ignatova, E., Massironi, S. M., Mashimo, T., Rios, X., Thalmann, I., Thalmann, 
R., and Ornitz, D. M. (2003). Non-syndromic vestibular disorder with otoconial agenesis 
in tilted/mergulhador mice caused by mutations in otopetrin 1. Hum Mol Genet 12, 777-
789. 
 148
Lee, S. C., Vielhauer, N. S., Leaver, E. V., and Pappone, P. A. (2005). Differential 
regulation of ca(2+) signaling and membrane trafficking by multiple p2 receptors in 
brown adipocytes. J Membr Biol 207, 131-142. 
 
Lorenz, H., Hailey, D. W., and Lippincott-Schwartz, J. (2006). Fluorescence protease 
protection of GFP chimeras to reveal protein topology and subcellular localization. Nat 
Methods 3, 205-210. 
 
Ornitz, D. M., Bohne, B. A., Thalmann, I., Harding, G. W., and Thalmann, R. (1998). 
Otoconial agenesis in tilted mutant mice. Hearing Res 122, 60-70. 
 
Sollner, C., Schwarz, H., Geisler, R., and Nicolson, T. (2004). Mutated otopetrin 1 affects 
the genesis of otoliths and the localization of Starmaker in zebrafish. Dev Genes Evol 
214, 582-590. 
 
Suzuki, H., Ikeda, K., Furukawa, M., and Takasaka, T. (1997). P2 purinoceptor of the 
globular substance in the otoconial membrane of the guinea pig inner ear. Am J Physiol 
273, C1533-1540. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 149
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
 
Technique for dissecting adult inner ear 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 150
 
 
 
 
 
 151
CURRICULUM VITAE 
Euysoo Kim 
 
? Education 
 
1998-2002 Korea Advanced Institute for Science and Technology (KAIST),  
                                       Taejon, Korea: B.S. with Honors in Biological Sciences 
 
2003-present                  Washington University School of Medicine, St. Louis, MO:   
                                       Candidate for the Ph.D. degree, Division of Biology and   
                                       Biomedical Sciences, Program in Molecular and Cellular  
                                       Biology 
 
? Research Experience 
 
Jun 2000-Jul 2002          Undergraduate Research, with Jongkyeong Chung, Ph.D.,  
                                        KAIST 
 
Sep 2002-Aug 2003       Research Assistant, with Jongkyeong Chung, Ph.D., KAIST 
 
Sep 2002-Dec 2003        Laboratory Rotation, with Yi Rao, Ph.D., Washington  
                                        University 
 
Jan 2004-present            Ph.D. Thesis Research, with David Ornitz, M.D., Ph.D.,  
                                        Washington University 
 
? Honors 
 
1998-2002                       Korean Government Scholarship, KAIST 
 
1999-2002                       Full Merit-Based Scholarship, KAIST 
 
2002                                Honors in Biological Sciences, Magna cum Laude, KAIST 
 
2009                                Viktor Hamburger Award, Washington University School of  
                                        Medicine, Department of Developmental Biology 
 
? Grant Support 
 
July 2004-June 2007       DC06974-01 “Otopetrin 1: a member of a novel family of  
                                        calcium regulating proteins” 
 
July 2007-present           DC02236 “Biological functions of Otopetrin gene family” 
 
 
 
 152
? Bibliography 
 
Publications:  
                                        Lee SB, Cho KS, Kim E, Chung J. (2003) blistery encodes  
                                        Drosophila tensin protein and interacts with integrin and the  
                                        JNK signaling pathway during wing development. Development  
                                        130:4001-4010. 
                                                       
                                        Lee JH, Lee E, Park J, Kim E, Kim J, Chung J. (2003) In vivo  
                                        p53 function is indispensable for DNA damage-induced  
                                        apoptosis signaling in Drosophila. FEBS Lett. 550:5-10. 
  
                                        Cha GH, Cho KS, Lee JH, Kim M, Kim E, Park J, Lee SB,  
                                        Chung J. (2003) Discrete functions of TRAF1 and TRAF2 in   
                                        Drosophila mediated by JNK- and NF-kB-dependent signaling  
                                        pathways. Mol. Cell. Biol. 23:7982-7991. 
 
                                        Kim E, Hyrc KL, Speck J, Lundberg YW, Hughes I, Salles FT,  
                                        Kachar B, Warchol ME, Ornitz DM. (2009) Regulation of  
                                        cellular calcium in vestibular supporting cells by Otopetrin 1.   
                                        Submitted. 
 
                                        Kim E, Hyrc KL, Speck J, Salles FT, Kachar B, Warchol ME,  
                                        Ornitz DM. Tilted and Mergulhador mutations differentially  
                                        disrupt Otopetrin 1 function. In preparation. 
 
                                        Kim E, Huss D, Ignatova E, Thalmann R, Thalmann IE, Ornitz  
                                        DM, Dickman JD. Comparison of otoconia weight and  
                                        expression of Otopetrin 1 and Otoconin 90 at normal and  
                                        hypergravity in developing quail. In preparation.  
                                         
Abstracts: 
                                        Kim E, Huss D, Ignatova E, Thalmann R, Thalmann IE,  
                                        Warchol M, Ornitz DM, Dickman JD. Spatiotemporal  
                                        expression profile of Otopetrin 1 and Otoconin 90 in developing  
                                        quail at normal and hypergravity. Society for Neuroscience.  
                                        Washington, DC: November 2005. 
 
                                        Kim E, Huss D, Ignatova E, Thalmann R, Thalmann IE,                              
                                        Warchol M, Ornitz DM, Dickman JD. Spatiotemporal  
                                        expression patterns of Otopetrin 1 and Otoconin 90 in  
                                        developing quail at normal and hypergravity. Association for   
                                        Research in Otolaryngology Mid-Winter Meeting. Baltimore,  
                                        MD: February 2006.   
 
                                         
 153
 
                                        Kim E, Hughes I, Lundberg YW, Bohne BA, Salles FT,     
                                        Kachar B, Warchol ME, Ornitz DM. Generation and   
                                        characterization of Otopetrin 1 knockout mice. Association for  
                                        research in Otolaryndology Mid-Winter Meeting. Pheonix, AZ:  
                                        February 2008 
 
                                        Kim E, Hughes I, Hyrc KL, Lundberg YW, Bohne BA,                
                                        Salles FT, Kachar B, Warchol ME, Ornitz DM. Otopetrin 1  
                                        regulates otoconia biomineralization in the vestibular sensory  
                                        epithelium. Mouse Genetics & Genomics: Development &  
                                        Disease Meeting. Cold Spring Harbor, NY: October 2008 
 
 
 
 
 
 
 
 
 
 154
